<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Mixed Bag-14) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 59982,
    "choices": [
      {
        "id": 239229,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Starts after peak of uterine contraction and ends after uterine contraction ends</span></span></p>"
      },
      {
        "id": 239230,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are smooth and gradual</span></span></p>"
      },
      {
        "id": 239231,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At least 10 beats, 2 times in a 20 min period above baseline</span></span></p>"
      },
      {
        "id": 239232,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not associated with accelerations</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which statement is false regarding late decelerations? (INICET NOV 2022) </span></span></p>",
    "unique_key": "Q4319019",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320568,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) At least 10 beats, 2 times in a 20 min period above baseline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The false statement about <strong>late decelerations</strong> among the given options is <strong>option C - At least 10 beats, 2 times in a 20 min period above baseline</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically, a late deceleration causes a <strong>fall in the fetal heart rate (FHR)</strong> by a depth of <strong>&lt;10 to 20 bpm below the baseline</strong>. It is usually not accompanied by accelerations (<strong>Option D</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late decelerations</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>smooth, gradual</strong> (<strong>Option B</strong>) symmetrical declines in the FHR that <strong>begin at or after the peak of uterine contraction and end only after the contraction has ended</strong> (<strong>Option A</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late decelerations are usually indicative of <strong>uteroplacental insufficiency and fetal hypoxia</strong>. Other causes of late decelerations include hypotension from epidural anesthesia, excessive use of oxytocin, maternal hypertension, diabetes, and placental abruption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A late deceleration plus <strong>decreased variability</strong> in FHR is predictive of <strong>fetal acidemia</strong> and neonatal morbidity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given <strong>CTG</strong> shows <strong>late decelerations</strong> and their relationship with the uterine contraction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Starts after peak of uterine contraction and ends after uterine contraction ends</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct. Late decelerations typically begin after the peak of the uterine contraction and persist beyond the end of the contraction. This is due to uteroplacental insufficiency and the delay in oxygen delivery to the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. They are smooth and gradual</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct. Late decelerations show a smooth and gradual decrease in fetal heart rate, usually due to reduced oxygenation of the fetus caused by impaired placental function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Not associated with accelerations</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct. Late decelerations are typically not associated with accelerations, which are indicative of fetal well-being. The absence of accelerations alongside late decelerations can suggest fetal distress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late decelerations</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are characterized by a gradual, symmetrical decrease in fetal heart rate that begins after the peak of uterine contractions and persists beyond their end. They are typically caused by <strong>uteroplacental insufficiency</strong> and are a concerning sign for <strong>fetal hypoxia</strong>.</span></span></span></p>",
    "correct_choice_id": 239231,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ]
  },
  {
    "id": 10246,
    "choices": [
      {
        "id": 40950,
        "text": "<p><span style=\"font-size:18px;\">She is immune to zoster</span></p>"
      },
      {
        "id": 40951,
        "text": "<p><span style=\"font-size:18px;\">She is susceptible to zoster</span></p>"
      },
      {
        "id": 40952,
        "text": "<p><span style=\"font-size:18px;\">She is susceptible to chicken pox</span></p>"
      },
      {
        "id": 40953,
        "text": "<p><span style=\"font-size:18px;\">She is immune to chicken pox</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A pregnant woman residing in the same house as her niece, who has contracted Varicella, received a negative result in her test for serum antibodies against varicella. What implications can be drawn from this? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
    "unique_key": "Q3795677",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320339,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p style=\"margin-left:-7px;\"><span style=\"font-size:18px;\"><strong>Ans. (c) She is susceptible to chicken pox</strong></span></p><p style=\"margin-left:-7px;\">&nbsp;</p><p style=\"margin-left:-7px;\"><span style=\"font-size:18px;\"><strong>Anti-Varicella/Varicella Zoster Virus (VZV)/Chickenpox IgG; Varicella immunity test</strong></span></p><p style=\"margin-left:-7px;\">&nbsp;</p><ul><li><span style=\"font-size:18px;\">Negative: Indicates no detectable Varicella IgG antibodies. A negative results indicate no current or previous infection with Varicella virus. Such individuals are presumed to be susceptible to primary infection.</span></li><li><span style=\"font-size:18px;\">Equivocal: Equivocal results are indeterminate. Patient may or may not have immunity to Varicella Virus. It is not acceptable proof of immunity.</span></li><li><span style=\"font-size:18px;\">Positive: Indicates evidence of Varicella IgG antibodies and suggests past or current infection with Varicella virus. Antibodies obtained via acquired immunity or immunization and probable protection from clinical infection. (Immunity).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>She is immune to zoster:&nbsp;</strong>Incorrect. Immunity to zoster (shingles) comes from having had a previous varicella (chicken pox) infection or vaccination. A negative antibody test indicates she has not had varicella.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>She is susceptible to zoster:&nbsp;</strong>Incorrect. Susceptibility to zoster (shingles) typically arises from a reactivation of the varicella virus in individuals who have previously had chicken pox. A negative test means she has not had chicken pox, so she cannot develop zoster but is susceptible to chicken pox.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>She is immune to chicken pox:&nbsp;</strong>Incorrect. A negative antibody test indicates she does not have immunity to chicken pox.</span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A negative test result for serum antibodies against varicella indicates that the individual is susceptible to chicken pox, as there are no detectable antibodies suggesting past infection or vaccination.</span></p>",
    "correct_choice_id": 40952,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 24718,
    "choices": [
      {
        "id": 98833,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MDR1</span></span></span></p>"
      },
      {
        "id": 98834,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></span></span></p>"
      },
      {
        "id": 98835,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2</span></span></span></p>"
      },
      {
        "id": 98836,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient undergoing renal transplant management was started on cyclosporine as part of the immunosuppressive regimen. Within a few weeks, the patient begins to show elevated liver enzymes and bilirubin levels. The treating physician suspects drug-induced cholestasis and considers the involvement of a specific cellular transporter. Which cellular transporter is most likely responsible for cyclosporine-induced cholestasis in this patient</span></span></span></p>",
    "unique_key": "Q1336214",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320613,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. MRP2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2, also known as Multi-Drug Resistance-associated Protein 2 or ABCC2, is a membrane-bound transporter protein that belongs to the ATP-binding cassette (ABC) family of transporters. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This protein is primarily expressed in the liver, particularly in the canalicular membrane of hepatocytes, as well as in the kidneys, intestines, and other tissues.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 functions as an efflux pump, actively transporting a variety of substances out of cells including bile salts, bilirubin, glucuronides, and various drugs and their metabolites.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 plays a critical role in the efflux of bile salts and bilirubin into the bile canaliculus. Mutations or inhibition of MRP2 (by drugs like cyclosporine) can lead to cholestasis, a condition where bile cannot flow from the liver to the duodenum.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dubin-Johnson Syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a genetic disorder resulting from mutations in the MRP2 gene, leading to conjugated hyperbilirubinemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. MDR 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Multi-Drug Resistance Protein 1 (MDR 1 or P-glycoprotein) is more known for its role in drug resistance, not specifically for cyclosporine-induced cholestasis. While MDR-1 plays a role in drug metabolism and can be inhibited by cyclosporine, it is generally not implicated in the development of drug-induced cholestasis, which is more closely associated with MRP2 inhibition.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The Breast Cancer Susceptibility Gene (BRCA) is not related to drug metabolism or cholestasis. It is mainly involved in DNA repair and cancer susceptibility.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Organic Anion Transporting Polypeptide 1B1 (OATP1B1) is involved in drug uptake into the liver but is not the key player in cyclosporine-induced cholestasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRP2 (Multi-Drug Resistance-associated Protein 2) is the cellular transporter most likely responsible for cyclosporine-induced cholestasis due to its role in the efflux of bile salts and bilirubin into the bile canaliculus.</span></span></span></p>",
    "correct_choice_id": 98835,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 10250,
    "choices": [
      {
        "id": 40966,
        "text": "<p><span style=\"font-size:18px;\">HALE</span></p>"
      },
      {
        "id": 40967,
        "text": "<p><span style=\"font-size:18px;\">DALY</span></p>"
      },
      {
        "id": 40968,
        "text": "<p><span style=\"font-size:18px;\">DFLE</span></p>"
      },
      {
        "id": 40969,
        "text": "<p><span style=\"font-size:18px;\">QALY</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>The typical lifespan for a Japanese woman is 87 years. Due to recent progress in cervical cancer testing, her life expectancy has risen by 15 years. With a healthcare utility value of 0.8, what can be determined based on these provided parameters? </strong><i><strong>[NEET PG 2022]</strong></i></span></p>",
    "unique_key": "Q5596505",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320336,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) QALY</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Quality Adjusted Life Years (QALYs)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">QALY is a measure of both quality and quantity of life lived</span></li><li><span style=\"font-size:18px;\">QALY is years of life lived in perfect health</span></li><li><span style=\"font-size:18px;\">QALY is used in assessing the value of money of a medical intervention</span></li><li><span style=\"font-size:18px;\">QALY calculation is simple: the change in utility value induced by the treatment is multiplied by the duration of the treatment effect to provide the number of QALYs gained</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. HALE: </strong>Health-adjusted life expectancy - equivalent number of years in \u201cfull health\u201d that a new-born can expect to live based on current rates of ill health and mortality</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. DALY:&nbsp;</strong>Is disability-adjusted life years, which is the best measure of disease burden, including both reduction in life expectancy and diminished quality of life. It can measure both mortality and disability together.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>DALY = YLL (years of life lost) + YLD (years lost to disability)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.&nbsp;</strong> <strong>Sullivan\u2019s Index</strong>, now called <strong>DFLE (Disability-free life expectancy):</strong>&nbsp;Means the average number of years an individual is expected to live free of disability (given the current mortality and disability). It is calculated as Life expectancy minus duration of disability</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">QALY (Quality Adjusted Life Years) is the measure used to assess the value of medical interventions by considering both the quality and quantity of life lived. In this scenario, the increase in life expectancy due to cervical cancer testing and the given utility value are used to calculate QALYs gained.</span></p>",
    "correct_choice_id": 40969,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 13133,
    "choices": [
      {
        "id": 52494,
        "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
      },
      {
        "id": 52495,
        "text": "<p><span style=\"font-size:12.0pt;\">Sertraline</span></p>"
      },
      {
        "id": 52496,
        "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
      },
      {
        "id": 52497,
        "text": "<p><span style=\"font-size:12.0pt;\">Fluvoxamine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient who is a known case of angle-closure glaucoma has been diagnosed with major depressive disorder. Which of the following drugs have to be avoided in this patient? (</span>INICET Nov 2021)</p>",
    "unique_key": "Q1980504",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320553,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amitriptyline</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Amitriptyline is a tricyclic antidepressant (TCA) that is known to have marked anticholinergic activity.</span></li><li><span style=\"font-size:12.0pt;\">TCAs have high affinity for muscarinic acetylcholine (M type) receptors, causing the subsequent blockade of these receptors.</span></li><li><span style=\"font-size:12.0pt;\">Blocking of these receptors can result in decreased outflow of aqueous humour, leading to an increase in intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">This effect can exacerbate pre-existing angle-closure type glaucoma, which is already characterized by impaired drainage of aqueous humour.</span></li><li><span style=\"font-size:12.0pt;\">Therefore, amitriptyline is a drug to be avoided in patients with angle-closure glaucoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options B and D:</strong> <strong>Sertraline and Fluvoxamine</strong> are selective serotonin reuptake inhibitors with no activity at the muscarinic cholinergic receptors and therefore have no effect on the outflow of aqueous humor and thereby, on the intraocular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> <strong>Mirtazapine </strong>is an atypical antidepressant that is a serotonin-norephedrine reuptake inhibitor with the ability to precipitate angle-closure glaucoma by itself; however, due to lack of any activity at the muscarinic cholinergic receptors, it does not increase the intraocular pressure to the extent that Amitriptyline does.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with angle-closure glaucoma, medications with anticholinergic properties, such as Amitriptyline, should be avoided due to their potential to increase intraocular pressure and exacerbate the condition.</span></p>",
    "correct_choice_id": 52494,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 57575,
    "choices": [
      {
        "id": 229669,
        "text": "<p><span style=\"font-size:18px;\">Perinatal mortality rate</span></p>"
      },
      {
        "id": 229670,
        "text": "<p><span style=\"font-size:18px;\">Maternal death rate</span></p>"
      },
      {
        "id": 229671,
        "text": "<p><span style=\"font-size:18px;\">Maternal mortality rate</span></p>"
      },
      {
        "id": 229672,
        "text": "<p><span style=\"font-size:18px;\">Maternal mortality ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Maternal deaths per 1,00,000 women in the reproductive age group is: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q2997698",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320312,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Maternal mortality rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The <strong>maternal mortality rate</strong> refers to the number of maternal deaths per 100,000 women of reproductive age (usually between 15 and 49 years) in a given time period. This rate considers the entire population of women in the reproductive age group and not just those giving birth. It helps in assessing the risk associated with pregnancy and childbirth among all women in the reproductive age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">PPH is the most common cause of Maternal mortality in India</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Perinatal mortality rate</strong>: This rate measures the number of stillbirths and deaths in the first week of life per 1,000 total births. It does not specifically pertain to maternal deaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Maternal death rate</strong>: Although similar in terminology, this option is not used commonly and does not fit the precise definition provided for maternal mortality metrics.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Maternal mortality ratio</strong>: This ratio measures the number of maternal deaths per 100,000 live births in a given time period. It specifically relates to deaths due to complications during pregnancy, childbirth, or within 42 days of termination of pregnancy but does not include the entire reproductive age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The <strong>maternal mortality rate</strong> measures the number of maternal deaths per 100,000 women in the reproductive age group, focusing on the general population of women of reproductive age rather than only those who have given birth.</span></p>",
    "correct_choice_id": 229671,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54316,
    "choices": [
      {
        "id": 216733,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a &amp; c</span></span></p>"
      },
      {
        "id": 216734,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a &amp; d</span></span></p>"
      },
      {
        "id": 216735,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, b, c</span></span></p>"
      },
      {
        "id": 216736,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of above </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is used in the treatment of hemophilia B?</span><span style=\"font-size:12.0pt\"> (multiple choice)</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a) &nbsp;Fresh Frozen Plasma (FFP)<br />\r\nb)&nbsp; Cryoprecipitate<br />\r\nc) &nbsp;Factor VIII concentrates<br />\r\nd) &nbsp;Cryo</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">poor Plasma</span></span></span></p>",
    "unique_key": "Q4585098",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320554,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) a</span></strong><strong><span style=\"font-size:12.0pt\"> &amp; </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">d</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilia B is a genetic bleeding disorder caused by a deficiency of factor IX. The primary treatment for hemophilia B involves the replacement of the missing factor IX.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment Options:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Factor IX concentrates:</strong> The specific treatment for hemophilia B is the administration of factor IX concentrates, which directly replace the deficient clotting factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a. Fresh Frozen Plasma (FFP):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> FFP contains all the clotting factors, including factor IX, in certain proportions. It can be used as a treatment for hemophilia B, especially in situations where factor IX concentrates are not available. FFP serves as a &quot;poor man&#39;s alternative&quot; due to its comprehensive content of clotting factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">d. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryopoor Plasma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is FFP from which the cryoprecipitate has been removed. While cryoprecipitate contains high levels of factor VIII, von Willebrand factor, and fibrinogen, the cryopoor plasma retains significant amounts of factor IX. Therefore, cryopoor plasma can be used as an alternative treatment for hemophilia B.</span><span style=\"font-size:12.0pt\"> (<strong>preferred over FFP</strong>)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">b. Cryoprecipitate:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This blood product is enriched with factor VIII, von Willebrand factor, and fibrinogen but contains little to no factor IX, making it unsuitable for treating hemophilia B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">c. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor VIII concentrates:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This treatment is specific to hemophilia A, which is caused by a deficiency of factor VIII. It is not effective for hemophilia B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment of hemophilia B primarily involves the administration of factor IX concentrates. Fresh Frozen Plasma (FFP) and cryopoor plasma are also viable options due to their content of factor IX. Factor VIII concentrates and cryoprecipitate are not suitable for hemophilia B as they do not contain significant levels of factor IX.</span></span></p>",
    "correct_choice_id": 216734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 57577,
    "choices": [
      {
        "id": 229677,
        "text": "<p><span style=\"font-size:18px;\">Paired student\u2019s t-test</span></p>"
      },
      {
        "id": 229678,
        "text": "<p><span style=\"font-size:18px;\">Unpaired student\u2019s t-test</span></p>"
      },
      {
        "id": 229679,
        "text": "<p><span style=\"font-size:18px;\">Chi-square test</span></p>"
      },
      {
        "id": 229680,
        "text": "<p><span style=\"font-size:18px;\">Wilcoxon test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A study was undertaken to evaluate the association between the consumption of vegetarian/non-vegetarian food with certain diseases. The incidence of disease was evaluated in those two groups. Which statistical test should be applied to test significance?</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q1548553",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320314,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Chi-square test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Chi-square test is used when evaluating the association between categorical variables, such as the consumption of vegetarian or non-vegetarian food and the incidence of certain diseases. This study involves comparing the occurrence of diseases in two groups (vegetarians vs. non-vegetarians), which represents qualitative data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>The Chi-square test is specifically designed for non-parametric data (data that does not follow a normal distribution)</strong> and is ideal for comparing proportions, percentages, or counts between two or more groups. In this context, the test helps determine whether there is a significant association between diet type and disease occurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.&nbsp; Paired student\u2019s t-test: </strong>The paired student\u2019s t-test is used for comparing means within the same group at two different times (before and after an intervention). It is suitable for continuous data, not for comparing categorical data between two distinct groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Unpaired student\u2019s t-test: </strong>The unpaired student\u2019s t-test compares the means of two independent groups, such as test scores or measurements. This test is used for continuous, normally distributed data and is not suitable for categorical or qualitative data like the incidence of diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Wilcoxon test: </strong>The Wilcoxon test is a non-parametric test used for comparing two paired groups when the data is not normally distributed. It is similar to the paired t-test but for ordinal or continuous data, making it unsuitable for categorical data such as disease incidence.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">The Chi-square test is used to determine the association between categorical variables, especially when comparing the incidence of outcomes across two or more independent groups.</span></p>",
    "correct_choice_id": 229679,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 5907,
    "choices": [
      {
        "id": 23598,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management</span></span></span></p>"
      },
      {
        "id": 23599,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up with beta-hCG</span></span></span></p>"
      },
      {
        "id": 23600,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction and evacuation</span></span></span></p>"
      },
      {
        "id": 23601,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with 12 weeks amenorrhea presents with vaginal bleeding. On examination, the cervical os is open and the uterus is 14 weeks size. USG shows a snowstorm appearance. The next best step in the management is?&nbsp;</span></span>(INICET NOV 2020)</p>",
    "unique_key": "Q8136026",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320545,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Suction and evacuation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The snowstorm appearance on ultrasound is characteristic of a complete molar pregnancy (hydatidiform mole). Molar pregnancies are abnormal pregnancies where there is an overgrowth of trophoblastic tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete Molar Pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Presents with vaginal bleeding, an enlarged uterus greater than expected for gestational age, and a snowstorm appearance on ultrasound.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The primary treatment for a molar pregnancy is suction and evacuation to remove the abnormal trophoblastic tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-Evacuation Surveillance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> After evacuation, it is crucial to monitor beta-hCG levels to ensure complete removal of the molar tissue and to detect any possible malignancy (e.g., choriocarcinoma).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Medical management:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Medical management is not appropriate for molar pregnancy, as surgical evacuation is necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Follow up with beta-hCG:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta-hCG monitoring is essential after the initial treatment but not before the evacuation of the molar tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hysterectomy is not the first line of treatment for a molar pregnancy unless there are specific complications or risk factors warranting such an invasive procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of a molar pregnancy involves suction and evacuation to remove the abnormal trophoblastic tissue, followed by post-evacuation surveillance with beta-hCG levels to monitor for persistent gestational trophoblastic disease or malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s Textbook of obstetrics 26<sup>th</sup> edition pg 614</span></strong></span></span></p>",
    "correct_choice_id": 23600,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 4198,
    "choices": [
      {
        "id": 16771,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline 100 mg intravenously for 7 days</span></p>"
      },
      {
        "id": 16772,
        "text": "<p><span style=\"font-size:12.0pt;\">Clindamycin 600 mg intravenously 8 hourly for 7 days</span></p>"
      },
      {
        "id": 16773,
        "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 2.4 mg/kg intravenously at 12 and 24 hours, followed by daily once</span></p>"
      },
      {
        "id": 16774,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine intramuscularly 8 hourly for 3 days</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with a history of high fever for 5 days and altered sensorium. On further probing, it was found that he had two seizures one day ago. Peripheral smear shows the following findings. How will you manage this patient?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/27.jpg\" alt=\"\" width=\"400\" height=\"236\"></span></p>",
    "unique_key": "Q1747982",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320611,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Artesunate 2.4 mg/kg intravenously at 12 and 24 hours, followed by daily once</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A Giemsa-stained peripheral blood smear shows many red blood cells (RBCs) infected with classic, <strong>ring-shaped and headphone-shaped trophozoites of Plasmodium falciparum parasite</strong>. High degree of parasitemia and RBCs infected with two or more trophozoites were seen, a finding typical of P. falciparum malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cerebral malaria is a complicated form of malaria associated with multisystem organ dysfunction and high degree of morbidity and mortality. These patients often present with impaired consciousness, delirium and convulsions. It is a medical emergency where prompt diagnosis and early institution of treatment can be lifesaving. Intravenous quinine or artesunate are the mainstays of treatment in cerebral malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of Cerebral Malaria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Artesunate</strong>: Administered intravenously at a dose of 2.4 mg/kg immediately, followed by 2.4 mg/kg at 12 and 24 hours, and then once daily if necessary.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alternative Treatment</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Artemether</strong>: 3.2 mg/kg intramuscularly initially, followed by 1.6 mg/kg once daily.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Quinine dihydrochloride</strong>: 20 mg of salt/kg infused over 4 hours, followed by 10 mg of salt/kg infused over 2-8 hours.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Doxycycline 100 mg intravenously for 7 days</strong>: Doxycycline is not the first-line treatment for severe malaria. It is typically used as a secondary prophylactic measure or in combination with other antimalarial drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Clindamycin 600 mg intravenously 8 hourly for 7 days:&nbsp;</strong>Clindamycin is not used for the treatment of malaria. It is an antibiotic that is used for bacterial infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chloroquine intramuscularly 8 hourly for 3 days</strong>: Chloroquine is ineffective against Plasmodium falciparum due to widespread resistance. It is also not suitable for treating severe or cerebral malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cerebral malaria caused by Plasmodium falciparum is a medical emergency requiring prompt treatment with intravenous artesunate, which is the most effective and rapid-acting medication for severe malaria.</span></p>",
    "correct_choice_id": 16773,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 60399,
    "choices": [
      {
        "id": 240893,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inside the membrane at the N-terminal end</span></span></p>"
      },
      {
        "id": 240894,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inside the membrane at the C-terminal end</span></span></p>"
      },
      {
        "id": 240895,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Outside the membrane at the N-terminal end</span></span></p>"
      },
      {
        "id": 240896,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Outside the membrane at the C-terminal end</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Where is the signaling sequence in a type 2 membrane protein located?</span><span style=\"background-color:lime\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>",
    "unique_key": "Q6495059",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320615,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Inside the membrane at the N-terminal end</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The signaling sequence in a type 2 membrane protein is located <strong>inside the membrane</strong> (transmembrane region) <strong>at the N-terminal end</strong>. This is important for the proper function and orientation of the protein in the cell membrane.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A membrane protein can either be an integral protein (spanning the membrane) or a peripheral protein (attached to one side of the membrane).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Integral membrane proteins</strong> span the entire membrane and are embedded in it. They are crucial for various functions such as signaling, transport, and cell communication.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Peripheral proteins</strong> attach to only one surface of the membrane and do not penetrate fully.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Signaling sequences</strong> are short chains of amino acids located at the <strong>N-terminal end</strong> of the membrane proteins. These sequences anchor the protein to the membrane and are either cleaved or act as membrane anchors for transporting proteins across the membrane.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Type II integral proteins</strong> specifically have a non-cleavable N-terminal signal/anchor sequence. Examples include transferrin receptors and glycosyl transferases.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Inside the membrane at the C-terminal end: </strong>This option is incorrect because type II integral proteins have their signaling sequences located at the <strong>N-terminal end</strong>, not the C-terminal end.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Outside the membrane at the N-terminal end: </strong>This option is incorrect because signaling sequences are <strong>inside the membrane</strong>, not outside.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Outside the membrane at the C-terminal end: </strong>This is incorrect because the signaling sequence for type 2 proteins is located at the N-terminal end inside the membrane.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The signaling sequence for a type 2 membrane protein is located <strong>inside the membrane at the N-terminal end</strong>, which anchors the protein to the membrane.</span></span></p>",
    "correct_choice_id": 240893,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ]
  },
  {
    "id": 20356,
    "choices": [
      {
        "id": 81385,
        "text": "<p><span style=\"font-size:18px;\">Adequate intake</span></p>"
      },
      {
        "id": 81386,
        "text": "<p><span style=\"font-size:18px;\">Dietary goal</span></p>"
      },
      {
        "id": 81387,
        "text": "<p><span style=\"font-size:18px;\">Estimated average requirement</span></p>"
      },
      {
        "id": 81388,
        "text": "<p><span style=\"font-size:18px;\">Recommended dietary allowance</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>The average daily dietary nutrient intake level sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals in a particular life stage and gender group is known as </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q7080807",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320333,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Recommended dietary allowance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Recommended Dietary Allowance (RDA) is a level of intake corresponding to Mean + 2 Standard Deviation, which covers requirement of 97.5% of population. RDA is safe level of intake which is likely to be inadequate in not more than 2.5% population. RDA is often higher than the recommended minimum requirement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Adequate intake</strong>: A value based on observed or experimentally determined approximations of nutrient intake by a group (or groups) of healthy people.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Dietary goals: </strong>are quantitative national targets for selected macronutrients and micronutrients aimed at preventing long-term chronic disease. They focus on population-level nutritional health.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. The estimated average requirement (EAR): </strong>Average daily level of intake estimated to meet the requirements of 50% of healthy individual\u2019s RDA is based on Estimated Average Requirement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Recommended Dietary Allowance (RDA)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Definition: RDA is a level of intake corresponding to Mean <u>+</u> 2 Standard Deviation, which covers requirement of 97.5% of population</span></li><li><span style=\"font-size:18px;\">RDA is safe level of intake which is likely to be inadequate in not more than 2.5% population</span></li><li><span style=\"font-size:18px;\">RDA is decided by a panel of experts and is based on scientific research</span></li><li><span style=\"font-size:18px;\">RDA is often higher than the recommended minimum requirement: RDA includes both daily requirement and some additional requirement for periods of growth or illness</span></li><li><span style=\"font-size:18px;\">RDA is based on Estimated Average Requirement</span></li><li><span style=\"font-size:18px;\">RDA \u2018safe level approach\u2019 is not used for energy since excess energy intake is undesirable.</span></li><li><span style=\"font-size:18px;\">For energy: only mean or average requirement is defined as RDA.</span></li></ul>",
    "correct_choice_id": 81388,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 4199,
    "choices": [
      {
        "id": 16775,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      },
      {
        "id": 16776,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
      },
      {
        "id": 16777,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
      },
      {
        "id": 16778,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaccination against which of the following is recommended in the elderly? (INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varicella zoster virus</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rotavirus</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Measles</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pneumococcal meningitis</span></span></span></li>\r\n</ol>",
    "unique_key": "Q8448861",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320548,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 1, 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The vaccination recommendations for the elderly typically include vaccines for Varicella Zoster Virus (to prevent shingles) and Pneumococcal meningitis (to prevent pneumococcal diseases, including meningitis).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Varicella Zoster Virus (VZV)</span></strong><span style=\"font-size:12.0pt\">: The recombinant zoster vaccine (RZV) is recommended for adults 50 years and older to prevent shingles and its complications.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pneumococcal meningitis</span></strong><span style=\"font-size:12.0pt\">: The pneumococcal vaccines (PCV13 and PPSV23) are recommended for adults 65 years and older to protect against pneumococcal diseases, including meningitis and pneumonia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/23/untitled-198.jpg\" style=\"height:572px; width:900px\" /></span></strong></span></span></p>",
    "correct_choice_id": 16777,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11177,
    "choices": [
      {
        "id": 44674,
        "text": "<p><span style=\"font-size:18px;\">Phosphatase test</span></p>"
      },
      {
        "id": 44675,
        "text": "<p><span style=\"font-size:18px;\">lodine test</span></p>"
      },
      {
        "id": 44676,
        "text": "<p><span style=\"font-size:18px;\">Standard plate count</span></p>"
      },
      {
        "id": 44677,
        "text": "<p><span style=\"font-size:18px;\">Methylene blue reduction test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>You are a nutritionist giving a lecture about milk pasteurization and its quality assurance tests. A curious student inquires about the various tests to validate the efficacy of pasteurization. You begin to list them, but highlight one that is not directly related to the pasteurization process. Which of the following tests does not directly evaluate the efficiency of milk pasteurization? </strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
    "unique_key": "Q7918606",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320550,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) lodine test&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Given tests are associated with the milk pasteurization process except for the iodine test.</span></li><li><span style=\"font-size:18px;\">This test is conducted to examine the potential adulteration of milk with starch or cereal flour.</span></li><li><span style=\"font-size:18px;\">Iodine test - The presence of addition of starch in milk can be detected using an iodine test.</span></li><li><span style=\"font-size:18px;\">When two or three drops of iodine solution is added to milk taken in a test tube, the solution turns dark blue.</span></li><li><span style=\"font-size:18px;\">This shows the presence of starch mixed with the milk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Phosphatase Test:</strong> Used to check for the presence of the enzyme phosphatase, which should be inactivated by proper pasteurization. This ensures that the milk has been heated sufficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Standard Plate Count:</strong> Measures the total bacterial count to ensure it meets the standards for pasteurized milk. A lower count indicates effective pasteurization.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Methylene Blue Reduction Test:</strong> Measures the time it takes for methylene blue to lose its color, which correlates with bacterial activity; high counts indicate inadequate pasteurization. This test helps verify the reduction of microbial load.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>PASTEURIZATION TESTS:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Phosphatase Test: Widely used test</span></li><li><span style=\"font-size:18px;\">Standard Plate Count: Standard is coliforms be absent in 1 ml of milk</span></li><li><span style=\"font-size:18px;\">Methylene blue reduction test: Enforced limit is 30,000 bacterial count per ml of pasteurized milk</span></li></ol>",
    "correct_choice_id": 44675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10248,
    "choices": [
      {
        "id": 40958,
        "text": "<p><span style=\"font-size:18px;\">History of similar illness in the past</span></p>"
      },
      {
        "id": 40959,
        "text": "<p><span style=\"font-size:18px;\">History of fever</span></p>"
      },
      {
        "id": 40960,
        "text": "<p><span style=\"font-size:18px;\">History of vaccination</span></p>"
      },
      {
        "id": 40961,
        "text": "<p><span style=\"font-size:18px;\">History of diet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A man from Chhattisgarh presented with a gradual onset of muscle weakness and spasms in his legs. Upon examination, he exhibited a specific loss of motor function. What inquiries should be made to gather the most relevant medical history from this patient? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
    "unique_key": "Q3775847",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320341,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) History of diet</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The clinical presentation suggests that the patient may have neurolathyrism, which is caused by the excessive consumption of Lathyrus sativus or Khesari dal.</span></li><li><span style=\"font-size:18px;\">To confirm the diagnosis, it is important to obtain the patient's dietary history.</span></li><li><span style=\"font-size:18px;\">Neurolathyrism is a paralytic condition caused by the consumption of Lathyrus sativus or Khesari dal, which is common in certain regions of India such as Madhya Pradesh, Uttar Pradesh, Chhattisgarh, Odisha, and Bihar.</span></li><li><span style=\"font-size:18px;\">The disease mainly affects the nervous system, causing gradual spastic paralysis of the lower limbs. It primarily affects males between the ages of 15 and 45 years and progresses through several stages.</span></li><li><span style=\"font-size:18px;\">The toxin responsible for the disease is BOAA (Beta oxalyl amino alanine), which is water-soluble and can be removed from the pulses by soaking them in hot water and discarding the water.</span></li><li><span style=\"font-size:18px;\">Large-scale detoxification can be achieved by parboiling the crop, or by overnight soaking in lime water followed by boiling.</span></li><li><span style=\"font-size:18px;\">Vitamin C in doses of 500-1000mg can help prevent and treat lathyrism.</span></li><li><span style=\"font-size:18px;\">In India, the Prevention of Food Adulteration Act prohibits the use of Lathyrus sativus in any form (whole/split/flour).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/04/screenshot-2023-10-04-111207.jpg\" alt=\"\" width=\"300\" height=\"322\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-144311.png\" alt=\"\" width=\"1000\" height=\"333\"></span></p>",
    "correct_choice_id": 40961,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54260,
    "choices": [
      {
        "id": 216509,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Almost never seen in heart with normal morphology</span></span></p>"
      },
      {
        "id": 216510,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV Digoxin can be used for ventricular rate control</span></span></p>"
      },
      {
        "id": 216511,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC Cardioversion is required in all cases</span></span></p>"
      },
      {
        "id": 216512,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discrepancy in HR and PR is a clinically reliable criteria for diagnosis</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 38-year-old man collapsed and was brought to the emergency. ECG was taken and a diagnosis of atrial fibrillation (AF) was made. Which of the following is true?</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101221.jpg\" style=\"height:248px; width:500px\" /></span></span></span></p>",
    "unique_key": "Q7883146",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320552,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B) IV Digoxin can be used for ventricular rate control</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atrial fibrillation (AF) is characterized by an irregularly irregular rhythm without distinct P waves on ECG, which confirms the diagnosis. Each of the provided options needs to be evaluated for accuracy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IV Digoxin can be used for ventricular rate control</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is the correct statement. IV Digoxin is used for rate control in AF, particularly in patients with heart failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If the patient is stable and not in acute heart failure, beta-blockers or non-dihydropyridine calcium channel blockers like verapamil or diltiazem are preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Almost never seen in heart with normal morphology</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This statement is incorrect. Atrial fibrillation can occur in morphologically normal hearts. Studies indicate that 15-35% of AF cases can be seen in individuals with structurally normal hearts, although it is more common in those with conditions such as heart failure or left atrial enlargement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><strong style=\"font-size:11pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DC Cardioversion is required in all cases</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">:</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.6667px; font-style:normal\">&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">This statement is incorrect. DC cardioversion is reserved for unstable patients or for rhythm control in selected chronic cases. It is not required for all AF cases.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong style=\"font-size:11pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Discrepancy in HR and PR is a clinically reliable criteria for diagnosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">:</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.6667px; font-style:normal\">&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">This statement is incorrect. While a pulse deficit (difference between heart rate and pulse rate) can suggest AF, it is not a reliable diagnostic criterion as it can be observed in other conditions such as frequent ventricular premature contractions, cardiac tamponade, and severe heart failure.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV Digoxin can be effectively used for ventricular rate control in patients with atrial fibrillation, especially in those with heart failure.</span></span></p>",
    "correct_choice_id": 216510,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 11809,
    "choices": [
      {
        "id": 47202,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, and 5</span></p>"
      },
      {
        "id": 47203,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 5 only</span></p>"
      },
      {
        "id": 47204,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 5 only</span></p>"
      },
      {
        "id": 47205,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, and 5 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient came to the outpatient department with complaints of neck swelling. She gives a history of weight loss and palpitations. On examination, she has exophthalmos and a diffusely enlarged thyroid gland. What are the essential investigations that should be done for the patient? (INICET NOV 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Thyroid scan</span></li><li><span style=\"font-size:12.0pt;\">Fine needle aspiration cytology (FNAC)</span></li><li><span style=\"font-size:12.0pt;\">Thyroid function tests</span></li><li><span style=\"font-size:12.0pt;\">Ultrasound of neck</span></li><li><span style=\"font-size:12.0pt;\">Anti-thyroid antibody</span></li></ol>",
    "unique_key": "Q5537454",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320556,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3, 4, and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of neck swelling, weight loss, palpitations, exophthalmos, and a diffusely enlarged thyroid gland suggests hyperthyroidism, likely Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FNAC is not recommended in this case because it does not provide additional diagnostic yield for Graves' disease, does not alter the treatment plan, and carries a risk of complications due to the gland's increased vascularity in Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following investigations are essential:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1<strong>. Thyroid scan</strong>: A radioactive iodine uptake scan helps differentiate between diffuse uptake (indicative of Graves' disease) and nodular uptake (indicative of toxic multinodular goiter or Plummer's disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3.<strong> Thyroid function tests</strong>: These are crucial as they provide information on the levels of thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH), helping confirm the diagnosis of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4<strong>. Ultrasound of neck</strong>: This imaging modality helps assess the thyroid gland's structure and can reveal increased vascularity, which is characteristic of Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. <strong>Anti-thyroid antibody</strong>: Testing for antibodies, such as TSH receptor antibodies (TRAbs) or thyroid-stimulating immunoglobulins (TSI), is important for diagnosing autoimmune thyroid diseases like Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient with clinical signs of hyperthyroidism and a diffusely enlarged thyroid gland, essential investigations include a thyroid scan, thyroid function tests, ultrasound of the neck, and anti-thyroid antibody tests. Fine needle aspiration cytology (FNAC) is not typically required in these cases.</span></p>",
    "correct_choice_id": 47205,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 10380,
    "choices": [
      {
        "id": 41486,
        "text": "<p><span style=\"font-size:12.0pt;\">Alport syndrome</span></p>"
      },
      {
        "id": 41487,
        "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture syndrome</span></p>"
      },
      {
        "id": 41488,
        "text": "<p><span style=\"font-size:12.0pt;\">IgA nephropathy</span></p>"
      },
      {
        "id": 41489,
        "text": "<p><span style=\"font-size:12.0pt;\">PSGN</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An 8-year-old boy with sensorineural hearing loss and eye defects presents to the OPD with hematuria. His renal biopsy on light microscopy was normal. Family history reveals the maternal uncle had Gr 5 CKD and is undergoing dialysis. Which of the following would be the probable diagnosis? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q8836377",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320563,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Alport syndrome.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-141312.png\" alt=\"\" width=\"1000\" height=\"549\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/108.jpg\" alt=\"\" width=\"491\" height=\"366\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A, Alport syndrome (EM), Note the presence of both the characteristic \u201cbasket- weave\u201d change (asterisks) and thinning of the GBM (arrows).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Goodpasture syndrome</strong>: Goodpasture syndrome is an immune-mediated disease characterised by antibodies against the alpha-3 chain of GBM type IV collagen; it is not hereditary, and light microscopy reveals extracapillary growth with crescents and necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span><span style=\"font-size:14px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>IgA nephropathy</strong></span><span style=\"font-size:12pt;\">: In IgA nephropathy, light microscopy would demonstrate focal mesangial proliferative glomerulonephritis and mesangial widening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:10.5pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>PSGN</strong>:&nbsp; In PSGN, light microscopy would reveal diffuse endocapillary proliferation with concomitant leukocytic infiltration in LM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Alport syndrome is a genetic disorder characterized by hematuria, sensorineural hearing loss, and ocular abnormalities, with characteristic findings on electron microscopy, including a \"basket-weave\" appearance of the glomerular basement membrane.</span></p>",
    "correct_choice_id": 41486,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 55625,
    "choices": [
      {
        "id": 221945,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High homocysteine and normal methylmalonic acid</span></span></span></p>"
      },
      {
        "id": 221946,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolytic anemia is a feature</span></span></span></p>"
      },
      {
        "id": 221947,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B12 supplementation is recommended along with Folate</span></span></span></p>"
      },
      {
        "id": 221948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Purine and pyrimidine synthesis are affected</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In folate deficiency, the False statement is:&nbsp;</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2024)</span></span></p>",
    "unique_key": "Q2616510",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320544,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Hemolytic anemia is a feature</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate deficiency primarily leads to megaloblastic anemia, which is characterized by large, immature red blood cells (macrocytes) in the bone marrow and blood due to impaired DNA synthesis. Folate is crucial for the synthesis of purines and pyrimidines, the building blocks of DNA, which is why DNA synthesis is directly affected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High homocysteine and normal methylmalonic acid:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In folate deficiency, homocysteine levels increase because folate is required for the remethylation of homocysteine to methionine. However, methylmalonic acid levels remain normal, which helps differentiate folate deficiency from vitamin B12 deficiency, where methylmalonic acid levels are elevated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B12 supplementation is recommended along with Folate:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is recommended because both vitamin B12 and folate deficiencies can lead to similar hematologic manifestations, like megaloblastic anemia. However, treating a patient with folic acid alone when they have an undiagnosed vitamin B12 deficiency can mask the hematologic symptoms while allowing neurological damage to progress. Therefore, it is safer to supplement both B12 and folate unless B12 deficiency has been ruled out.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Purine and pyrimidine synthesis are affected:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Folate is essential for the synthesis of purines and pyrimidines, which are necessary for DNA replication. Specifically, folate is involved in the transfer of one-carbon units during the synthesis of these nucleotides. In its absence, DNA synthesis is impaired, leading to megaloblastic anemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. High homocysteine and normal methylmalonic acid:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This statement is true and correctly describes the biochemical changes in folate deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. B12 supplementation is recommended along with Folate:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a true statement and an important clinical practice to avoid masking B12 deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Purine and pyrimidine synthesis are affected:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This statement is true because folate is directly involved in nucleotide synthesis, which is critical for DNA replication and repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate deficiency leads to megaloblastic anemia, not hemolytic anemia. It is associated with high homocysteine levels and normal methylmalonic acid levels, and folate is essential for purine and pyrimidine synthesis, which are necessary for DNA synthesis</span></span></span></p>",
    "correct_choice_id": 221946,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11198,
    "choices": [
      {
        "id": 44758,
        "text": "<p><span style=\"font-size:18px;\">Malaria</span></p>"
      },
      {
        "id": 44759,
        "text": "<p><span style=\"font-size:18px;\">Dengue</span></p>"
      },
      {
        "id": 44760,
        "text": "<p><span style=\"font-size:18px;\">Sexually transmitted infections</span></p>"
      },
      {
        "id": 44761,
        "text": "<p><span style=\"font-size:18px;\">AIDS</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>For which medical condition is the provided drug typically recommended? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip53.jpg\" alt=\"\" width=\"400\" height=\"370\"></strong></span></p>",
    "unique_key": "Q6319038",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320623,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Malaria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The picture depicts artemisin-based combination therapy (ACT). This medicine is used to treat falciparum malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>ARTEMISINS - </strong>Artesunate and Artemether</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Fastest acting anti-malarial</span></li><li><span style=\"font-size:18px;\">Effective against MDR parasites</span></li><li><span style=\"font-size:18px;\">Short acting</span></li><li><span style=\"font-size:18px;\">C/I in 1st trimester</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Artemisin Combination Therapy [ACT]</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Artemisin + Long acting drug</span></li><li><span style=\"font-size:18px;\">DOC for chloroquine resistant malaria Combinations</span></li><li><span style=\"font-size:18px;\">Artemether + Lumefantrine: DOC in North Eastern States</span></li><li><span style=\"font-size:18px;\">Artesunate + Sulfadoxine-Pyrimethamine: DOC for rest of India</span></li><li><span style=\"font-size:18px;\">The dose of artesunate is 200 mg OD for 3 days whereas sulfadoxine (1500 mg) and pyrimethamine (75 mg) should be taken on day 1 only</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Artemisinin-based combination therapy (ACT), is typically recommended for the treatment of falciparum malaria.</span></p>",
    "correct_choice_id": 44758,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 10260,
    "choices": [
      {
        "id": 41006,
        "text": "<p><span style=\"font-size:18px;\">Children from the area exposed, but unaffected with the disease</span></p>"
      },
      {
        "id": 41007,
        "text": "<p><span style=\"font-size:18px;\">Children from the area not exposed and affected with the disease</span></p>"
      },
      {
        "id": 41008,
        "text": "<p><span style=\"font-size:18px;\">Children coming to the OPD who do not have the disease</span></p>"
      },
      {
        "id": 41009,
        "text": "<p><span style=\"font-size:18px;\">All children with ALL irrespective of exposure status</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Numerous youngsters from a specific community arrived at a medical facility and were diagnosed with acute lymphoblastic leukemia (ALL). It was assumed that it is due to the presence of cytotoxic waste in the water of that community. If a case-control investigation were to be conducted to find the potential association between the chemical waste and ALL, what would serve as the control group? </strong><i><strong>[NEET PG 2022]</strong></i></span></p>",
    "unique_key": "Q9001483",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320337,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Children coming to the OPD who do not have the disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Case control study: A study that compares patients who have a disease or outcome of interest (cases) with patients who do not have the disease or outcome (controls), and looks back retrospectively to compare how frequently the exposure to a risk factor is present in each group to determine the relationship between the risk factor and the disease</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a case control study, we never try to match the actual risk factor under study</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a case-control study investigating the association between chemical waste exposure and acute lymphoblastic leukemia (ALL), the control group should consist of children coming to the OPD who do not have the disease (ALL). This ensures a proper baseline for comparison to identify potential risk factors associated with the disease.</span></p>",
    "correct_choice_id": 41008,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10261,
    "choices": [
      {
        "id": 41010,
        "text": "<p><span style=\"font-size:18px;\">Use MR vaccine and discard pentavalent vaccine</span></p>"
      },
      {
        "id": 41011,
        "text": "<p><span style=\"font-size:18px;\">Use pentavalent vaccine and discard MR vaccine</span></p>"
      },
      {
        "id": 41012,
        "text": "<p><span style=\"font-size:18px;\">Use both</span></p>"
      },
      {
        "id": 41013,
        "text": "<p><span style=\"font-size:18px;\">Discard both</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>An auxiliary nurse midwife is tasked with organizing a vaccination camp within a rural community. She has been provided with 2 vials that have been unsealed. Among these, one contains a pentavalent vaccine, while the other holds an MR vaccine. What options does she have in terms of effectively using these vials?</strong><i><strong> [NEET PG 2022]</strong></i></span></p>",
    "unique_key": "Q1138432",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320338,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Use pentavalent vaccine and discard MR vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">According to the Open Vial Policy, certain vaccines can be used for subsequent sessions for up to 4 weeks after opening, provided they have been stored properly and are not expired. This policy helps to minimize vaccine wastage and ensure efficient use of available vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Open Vial Policy (2015)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Opened vaccine vials can be used in subsequent session \u2018UPTO 4 WEEKS\u2019</span></li><li><span style=\"color:black;font-size:18px;\">Open vial policy \u2013&nbsp;</span><ul><li><span style=\"color:black;font-size:18px;\">Applicable for - Hep B, OPV, DPT, Liquid pentavalent, TT, PCV, IPV, HiB</span></li><li><span style=\"color:black;font-size:18px;\">Not applicable for - BCG, MR, JE, RVV, Covid-19 vaccines</span></li></ul></li><li><span style=\"font-size:18px;\">Expiry date should not pass, VVM within usability limits, Cold chain maintenance</span></li><li><span style=\"font-size:18px;\">Vaccine vial septum not submerged in water or contaminated, Aseptic technique used to withdraw doses</span></li><li><span style=\"font-size:18px;\">Record date and time of each vial opening</span></li><li><span style=\"font-size:18px;\">At end of session return all open vials to Cold chain:</span><ul><li><span style=\"font-size:18px;\">Reusable open vials: DPT, DT, Hepatitis B, Pentavalent</span></li><li><span style=\"font-size:18px;\">Non-reusable open vials: Measles, BCG, JE (Destroy after 48 hours or Next session whichever earlier)</span></li><li><span style=\"font-size:18px;\">If any AEFI reported: Store all vials in Cold chain till completion of investigation</span></li></ul></li></ul><p style=\"margin-left:15px;\">&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Under the Open Vial Policy, the auxiliary nurse midwife can use the pentavalent vaccine for subsequent sessions up to 4 weeks after opening, but must discard the MR vaccine as it does not fall under the Open Vial Policy.</span></p>",
    "correct_choice_id": 41011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 20357,
    "choices": [
      {
        "id": 81389,
        "text": "<p><span style=\"font-size:18px;\">Isolate for 6 days after giving acyclovir, followed by VZIG within 72 hours of exposure</span></p>"
      },
      {
        "id": 81390,
        "text": "<p><span style=\"font-size:18px;\">Isolate for 12 days after giving acyclovir, followed by VZIG within 48 hours of exposure</span></p>"
      },
      {
        "id": 81391,
        "text": "<p><span style=\"font-size:18px;\">Isolate for 6 days</span></p>"
      },
      {
        "id": 81392,
        "text": "<p><span style=\"font-size:18px;\">Only give VZIG</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A boys' hostel has an outbreak of fever cases with headache, followed by the development of pleomorphic rashes sparing palms and soles. What is the next best step in the management of suspected cases? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q5630076",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320334,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Isolate for 6 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The given scenario points to the diagnosis of chickenpox.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a boys' hostel, everyone is not in the high-risk groups for severe varicella infection. For the management of suspected cases in this situation, isolation for 6 days from the onset of the rash is the appropriate measure to prevent further spread of the infection. Acyclovir and ZIG are not necessary for healthy individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Varicella zoster immunoglobulin (VZIG) is indicated as prophylaxis for individuals at high risk like Immunocompromised individuals, Pregnant women and Newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-190121030.jpg\" alt=\"\" width=\"300\" height=\"342\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Note \u2013</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Acyclovir:&nbsp;</strong>Antiviral treatment with acyclovir is generally reserved for high-risk groups or severe cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>VZIG (Varicella Zoster Immunoglobulin):&nbsp;</strong>VZIG is indicated for individuals at high risk of severe varicella infection, such as immunocompromised individuals, pregnant women, and newborns. It is not routinely given to healthy individuals in a setting like a boys' hostel.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">For managing a chickenpox outbreak in a boys' hostel, the best step is to <strong>isolate affected individuals for 6 days</strong> from the onset of the rash. This helps prevent the spread of the virus. Antiviral treatments and immunoglobulins are reserved for high-risk individuals.</span></p>",
    "correct_choice_id": 81391,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 6071,
    "choices": [
      {
        "id": 24254,
        "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
      },
      {
        "id": 24255,
        "text": "<p><span style=\"font-size:12pt;\">4</span></p>"
      },
      {
        "id": 24256,
        "text": "<p><span style=\"font-size:12pt;\">6</span></p>"
      },
      {
        "id": 24257,
        "text": "<p><span style=\"font-size:12pt;\">10</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">According to new WHO guidelines, what is the minimum number of antenatal visits recommended to have a positive pregnancy outcome?</span><span style=\"font-size:12.0pt;\">&nbsp;</span>(INICET NOV 2022)</p>",
    "unique_key": "Q6174537",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320555,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The World Health Organization (WHO) updated its guidelines in 2016, recommending a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality. This guideline is structured to ensure comprehensive monitoring and support throughout the pregnancy:</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12pt;\"><strong>1st Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 1: up to 12 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>2nd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 2: at 20 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 3: at 26 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>3rd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 4: at 30 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 5: at 34 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 6: at 36 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 7: at 38 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 8: at 40 weeks</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These visits are designed to monitor the health of the mother and fetus, provide timely interventions, and offer essential health education.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The WHO recommends a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: The 2016 WHO model for positive pregnancy experience, MOHFW guidelines for antenatal care, ACOG guidelines for antenatal care (2017).</strong></span></p>",
    "correct_choice_id": 24254,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 57573,
    "choices": [
      {
        "id": 229661,
        "text": "<p><span style=\"font-size:18px;\">1 only</span></p>"
      },
      {
        "id": 229662,
        "text": "<p><span style=\"font-size:18px;\">1, 2 only</span></p>"
      },
      {
        "id": 229663,
        "text": "<p><span style=\"font-size:18px;\">All three</span></p>"
      },
      {
        "id": 229664,
        "text": "<p><span style=\"font-size:18px;\">2 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>HDI is calculated by using ?</strong><i><strong>&nbsp;[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Life expectancy at birth</strong></span></li><li><span style=\"font-size:18px;\"><strong>Mean years of schooling</strong></span></li><li><span style=\"font-size:18px;\"><strong>Gross national product</strong></span></li></ol>",
    "unique_key": "Q2992707",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320310,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) All three</strong></span></p><p><br><span style=\"font-size:18px;\">The Human Development Index (HDI) is a composite index used to measure the overall achievement of a country in three basic dimensions of human development:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Health:</strong> Measured by life expectancy at birth, which reflects the average number of years a newborn is expected to live if current mortality rates continue to apply.</span></li><li><span style=\"font-size:18px;\"><strong>Education:</strong> Measured by the mean years of schooling for adults aged 25 years or older and expected years of schooling for children entering school. This represent knowledge, enrolment ratio.</span></li><li><span style=\"font-size:18px;\"><strong>Living Standards:</strong> Measured by Gross National Income (GNI) per capita, expressed in terms of purchasing power parity (PPP) in US dollars.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:18px;\">These components together provide a summary measure of average achievement in key dimensions of human development, allowing for comparisons across countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\">HDI is calculated using three components: life expectancy at birth, mean years of schooling, and Gross National Income per capita. These factors represent health, education, and living standards, respectively.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>HDI range \u2013 0 to +1</strong></span></li><li><span style=\"font-size:18px;\"><strong>HDI (India) \u2013 0.644 (Rank 134)</strong></span></li><li><span style=\"font-size:18px;\"><strong>HDI (Switzerland) \u2013 0.96 (Rank 1)</strong></span></li></ul>",
    "correct_choice_id": 229663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InstrumentsBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57581,
    "choices": [
      {
        "id": 229693,
        "text": "<p><span style=\"font-size:18px;\">Impact \u2013 Response \u2013 Rehabilitation</span></p>"
      },
      {
        "id": 229694,
        "text": "<p><span style=\"font-size:18px;\">Response \u2013 Rehabilitation \u2013 Reconstruction</span></p>"
      },
      {
        "id": 229695,
        "text": "<p><span style=\"font-size:18px;\">Response \u2013 Rehabilitation \u2013 Mitigation</span></p>"
      },
      {
        "id": 229696,
        "text": "<p><span style=\"font-size:18px;\">Rehabilitation \u2013 Reconstruction \u2013 Mitigation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Components of Disaster cycle that can be included in the recovery phase are: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q2918989",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320317,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Response \u2013 Rehabilitation \u2013 Reconstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/untitled-133333333.jpg\" alt=\"\" width=\"400\" height=\"383\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The disaster cycle consists of several phases: impact, response, rehabilitation, reconstruction, mitigation, and preparedness.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The recovery phase specifically focuses on restoring the affected area to normalcy and includes three key components: <strong>R</strong>esponse<strong>, R</strong>ehabilitation, and <strong>R</strong>econstruction (<strong>Mnemonic: 3Rs</strong>). These steps are crucial for rebuilding after a disaster, addressing immediate needs (response), restoring essential services (rehabilitation), and rebuilding infrastructure (reconstruction).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\">The recovery phase of the disaster cycle includes the components of Response, Rehabilitation, and Reconstruction, which are essential for restoring the community post-disaster.</span></p>",
    "correct_choice_id": 229694,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 20358,
    "choices": [
      {
        "id": 81393,
        "text": "<p><span style=\"font-size:18px;\">Infant mortality rate</span></p>"
      },
      {
        "id": 81394,
        "text": "<p><span style=\"font-size:18px;\">Maternal mortality rate</span></p>"
      },
      {
        "id": 81395,
        "text": "<p><span style=\"font-size:18px;\">Immunization coverage</span></p>"
      },
      {
        "id": 81396,
        "text": "<p><span style=\"font-size:18px;\">Disability-adjusted life years</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the following is the sensitive indicator to assess the availability, utilization, and effectiveness of healthcare in a community? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q1479842",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320335,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Infant mortality rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Infant Mortality Rate (IMR)</strong> is considered the most sensitive indicator to assess the availability, utilization, and effectiveness of healthcare in a community. IMR reflects the overall health and well-being of infants and the quality of maternal and infant care services. It is a comprehensive measure that can indicate various aspects of public health, including nutritional status, access to medical care, public health practices, and the socio-economic conditions of the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>IMR = (Number of deaths in the first year of life/Total number of live births) \u00d7 1000.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>SRS 2022-23 Latest data</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-190121027.jpg\" alt=\"\" width=\"700\" height=\"171\"></span></p>",
    "correct_choice_id": 81393,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 14332,
    "choices": [
      {
        "id": 57289,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancreatic fistula</span></p>"
      },
      {
        "id": 57290,
        "text": "<p><span style=\"font-size:12.0pt;\">Duodenal fistula</span></p>"
      },
      {
        "id": 57291,
        "text": "<p><span style=\"font-size:12.0pt;\">Distal ileal fistula</span></p>"
      },
      {
        "id": 57292,
        "text": "<p><span style=\"font-size:12.0pt;\">Colonic fistula</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Mrs. Johnson is a 60-year-old woman who underwent a Whipple's procedure for pancreatic cancer three weeks ago. She developed a fever and abdominal pain, and her surgeon suspected a postoperative complication. Which of the following complications causes maximum malnutrition?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q4220342",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320558,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Duodenal fistula</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Among the given conditions, maximum malnutrition is caused by duodenal fistulas.</span></li><li><span style=\"font-size:12.0pt;\">Enterocutaneous fistulas are classified based on their location and volume of daily output.</span></li><li><span style=\"font-size:12.0pt;\">Proximal fistulas have higher output and are associated with greater fluid, electrolyte, and digestive capacity loss.</span></li><li><span style=\"font-size:12.0pt;\">Distal fistulas have lower output and are easier to manage, with a higher likelihood of spontaneous closure.</span></li><li><span style=\"font-size:12.0pt;\">Duodenal fistulas receive an additional 1 to 2 liters of enzymes, electrolytes, and water from the pancreatic and bile ducts, making them more susceptible to electrolyte imbalances than gastric fistulas.</span></li><li><span style=\"font-size:12.0pt;\">The management of enterocutaneous fistulas follows the SNAP principles:</span><ul><li><span style=\"font-size:12.0pt;\">S: Sepsis elimination and skin protection</span></li><li><span style=\"font-size:12.0pt;\">N: A period of parenteral nutrition may be required</span></li><li><span style=\"font-size:12.0pt;\">A: Anatomical assessment</span></li><li><span style=\"font-size:12.0pt;\">P: Definitive planned surgery.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A duodenal fistula involves a connection between the duodenum (the first part of the small intestine) and an unintended location, such as the abdominal cavity. This can result in severe malnutrition because the duodenum is a critical site for nutrient absorption in the digestive process. A duodenal fistula can lead to the loss of digestive juices and nutrients, significantly impacting a patient's nutritional status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pancreatic fistula</strong>: A pancreatic fistula is a complication where pancreatic fluids leak from the surgical site. While it can lead to malnutrition due to the loss of digestive enzymes, it is not typically as severe as a duodenal fistula in causing malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Distal ileal fistula</strong>: While a distal ileal fistula can disrupt nutrient absorption to some extent, it is not as critical as a duodenal fistula in terms of causing maximum malnutrition. The ileum is further down the small intestine, and its role in nutrient absorption is not as central as that of the duodenum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Colonic fistula</strong>: A colonic fistula may lead to the loss of stool and fluids but is not primarily responsible for causing severe malnutrition in the same way as a duodenal fistula. The colon's main function is to absorb water and electrolytes, not nutrients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A duodenal fistula (option B) is the postoperative complication that can cause maximum malnutrition due to its disruption of nutrient absorption in the critical site of the digestive process, the duodenum.</span></p>",
    "correct_choice_id": 57290,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 34044,
    "choices": [
      {
        "id": 136011,
        "text": "<p><span style=\"font-size:12.0pt;\">By increasing osteoclast activity</span></p>"
      },
      {
        "id": 136012,
        "text": "<p><span style=\"font-size:12.0pt;\">By increasing osteoblastic activity</span></p>"
      },
      {
        "id": 136013,
        "text": "<p><span style=\"font-size:12.0pt;\">By decreasing renal excretion</span></p>"
      },
      {
        "id": 136014,
        "text": "<p><span style=\"font-size:12.0pt;\">By increasing osteoclastic activity and decreasing renal excretion of calcium</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The adjoining graph shows the effect of PTH on blood calcium and phosphate in an experimental animal. How does PTH increase plasma calcium? (INICET NOVEMBER 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/29/picture10_vgzKlLM.jpg\" alt=\"\" width=\"300\" height=\"170\"></span></p>",
    "unique_key": "Q9223555",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320564,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) By increasing osteoclastic activity and decreasing renal excretion of calcium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PTH increases calcium levels by promoting osteoclast-mediated bone resorption and reducing the kidneys' excretion of calcium, effectively increasing plasma calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>By increasing osteoclast activity:</strong> Parathyroid hormone (PTH) stimulates osteoclasts indirectly, leading to increased bone resorption, which releases calcium into the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>By increasing osteoblastic activity:</strong> While PTH does stimulate osteoblasts, this action is primarily to produce RANKL, a cytokine that activates osteoclasts, not to build new bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>By decreasing renal excretion:</strong> PTH reduces calcium excretion by the kidneys, increasing reabsorption of calcium in the renal tubules, contributing to higher blood calcium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parathyroid hormone (PTH) increases plasma calcium levels by promoting osteoclast-mediated bone resorption and reducing renal excretion of calcium.</span></p>",
    "correct_choice_id": 136014,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 73226,
    "choices": [
      {
        "id": 291861,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Meissner\u2019s corpuscles</span></p>"
      },
      {
        "id": 291862,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Merkel disk</span></p>"
      },
      {
        "id": 291863,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pacinian corpuscles</span></p>"
      },
      {
        "id": 291864,
        "text": "<p><span style=\"font-size:16px;\">Ruffini ending&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is involved in Static Two-point discrimination? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8960900",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320547,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Merkel disk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Static two-point discrimination requires a receptor that <strong>adapts very slowly to maintain sensation over a prolonged period.</strong> Merkel cells are crucial for this function.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Merkel cells:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">They are <strong>slow-adapting receptors</strong></span></li><li><span style=\"font-size:16px;\"><strong>Excellent for 2-point discrimination</strong></span></li><li><span style=\"font-size:16px;\">Have a <strong>less</strong> receptive field</span></li><li><span style=\"font-size:16px;\">Critical for detecting <strong>edges and points</strong></span></li><li><span style=\"font-size:16px;\">Particularly important for tasks like <strong>Braille reading</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The key characteristics that make Merkel cells ideal for static two-point discrimination are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Slow adaptation rate</span></li><li><span style=\"font-size:16px;\">Ability to detect <strong>steady stimuli</strong></span></li><li><span style=\"font-size:16px;\">Precise localization of sensory input</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Meissner's corpuscles</strong>: Incorrect. These are rapidly adapting receptors, making them unsuitable for static discrimination. They are best for fine touch sensations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Pacinian corpuscles:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>These are rapidly adapting receptors present at Deep dermis, joint capsule that <strong>sense high-frequency vibration and pressure</strong>, not static stimuli.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Ruffini ending:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>While these are slow-adapting mechanoreceptors, they primarily sense <strong>stretch and sustained pressure,</strong> not precise point discrimination.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bKoOXLC.png\" width=\"1039\" height=\"633\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_g0UtPCH.png\" width=\"1039\" height=\"374\"></strong></span></p>",
    "correct_choice_id": 291862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6005,
    "choices": [
      {
        "id": 23990,
        "text": "<p><span style=\"font-size:12pt;\">Immunosuppression can be continued during pregnancy</span></p>"
      },
      {
        "id": 23991,
        "text": "<p><span style=\"font-size:12pt;\">Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</span></p>"
      },
      {
        "id": 23992,
        "text": "<p><span style=\"font-size:12pt;\">High dose corticosteroids for lupus flare in pregnancy is safe</span></p>"
      },
      {
        "id": 23993,
        "text": "<p><span style=\"font-size:12pt;\">Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is not true about lupus nephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
    "unique_key": "Q3092800",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320567,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">SLE is a chronic autoimmune disorder involving the multisystem. It affects young women of childbearing age. The renal involvement of the disease can manifest in the form of active lupus nephritis or flare-ups during pregnancy.</span></li><li><span style=\"font-size:12pt;\">It can lead to preterm births, preeclampsia, and pregnancy loss while the infant can suffer from neonatal lupus and heart block.</span></li><li><span style=\"font-size:12pt;\">Management includes</span></li><li><span style=\"font-size:12pt;\">Preconceptionally counseling: Conception during a period of quiescence for at least 6 months determines a successful outcome. Stable remission of renal disease for at least 6 months before conception is recommended.</span></li><li><span style=\"font-size:12pt;\">Corticosteroids are useful during episodes of lupus flare and can be used safely in pregnancy.</span></li><li><span style=\"font-size:12pt;\">Immunosuppressants such as azathioprine can be continued during pregnancy. It may be used in case of severe SLE</span></li><li><span style=\"font-size:12pt;\">Hydroxychloroquine is found to be the best for maintenance and is safe in pregnancy. It can prevent the need for prolonged corticosteroid therapy.</span></li><li><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are teratogenic and hence they are not safe during pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immunosuppression can be continued during pregnancy</strong>: Correct. Medications like azathioprine can be continued under medical guidance, while others are used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</strong>: Correct. Quiescence of the disease and stable renal function are crucial for a successful pregnancy outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High dose corticosteroids for lupus flare in pregnancy is safe</strong>: Correct. High doses of corticosteroids can be used during a lupus flare, but must be carefully monitored.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are not safe during pregnancy for managing lupus nephritis; corticosteroids and azathioprine are safer options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2895, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 23993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 63615,
    "choices": [
      {
        "id": 253665,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 c, 2 \u2192 a, 3 \u2192 d, 4 \u2192 b</span></p>"
      },
      {
        "id": 253666,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 a, 2 \u2192 b, 3 \u2192 c, 4 \u2192 d</span></p>"
      },
      {
        "id": 253667,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 d, 2 \u2192 c, 3 \u2192 b, 4 \u2192 a</span></p>"
      },
      {
        "id": 253668,
        "text": "<p><span style=\"font-size:12.0pt;\">1 \u2192 b, 2 \u2192 d, 3 \u2192 a, 4 \u2192 c</span></p>"
      }
    ],
    "text": "<p>Match the following anesthetic agents with respect to their side effects.&nbsp;</p><p>&nbsp;</p><p><strong>Column A:</strong></p><p>1. Propofol</p><p>2. Fentanyl</p><p>3. Midazolam</p><p>4. Nitrous oxide</p><p>&nbsp;</p><p><strong>Column B:</strong></p><p>a. Rigid chest syndrome</p><p>b. Pulmonary vasoconstriction</p><p>c. Egg allergy</p><p>d. Hypotension</p>",
    "unique_key": "Q9225191",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320612,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><strong>Ans. A) 1 \u2192 c, 2 \u2192 a, 3 \u2192 d, 4 \u2192 b</strong></p><p>&nbsp;</p><ol><li><strong>Propofol \u2192 Egg allergy (c):&nbsp;</strong>Propofol is a lipid-soluble anesthetic agent that is formulated with soybean oil, glycerol, and egg phospholipids. Due to the inclusion of egg components, there is a potential risk of allergic reactions, particularly in patients with a known egg allergy.</li><li><strong>Fentanyl \u2192 Rigid chest syndrome (a):&nbsp;</strong>Fentanyl is a potent opioid analgesic that can cause severe muscle rigidity, particularly in the chest wall, which is known as rigid chest syndrome. This side effect is significant because it can make ventilation difficult during anesthesia.</li><li><strong>Midazolam \u2192 Hypotension (d):&nbsp;</strong>Midazolam is a benzodiazepine that induces sedation and vasodilatation, which may lead to a decrease in blood pressure, causing hypotension. This effect is dose-dependent and more pronounced in patients with pre-existing cardiovascular issues.</li><li><strong>Nitrous oxide \u2192 Pulmonary vasoconstriction (b):&nbsp;</strong>Nitrous oxide is known to cause pulmonary vasoconstriction, which can increase pulmonary vascular resistance. This effect may be problematic in patients with pre-existing pulmonary hypertension or cardiovascular conditions.</li></ol><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Propofol</strong>: Risk of egg allergy due to its lipid formulation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fentanyl</strong>: Can cause rigid chest syndrome, making ventilation difficult.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Midazolam</strong>: May lead to hypotension through vasodilatation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nitrous oxide</strong>: Can cause pulmonary vasoconstriction, increasing pulmonary vascular resistance.</span></li></ul>",
    "correct_choice_id": 253665,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ]
  },
  {
    "id": 50947,
    "choices": [
      {
        "id": 203329,
        "text": "<p><span style=\"font-size:12.0pt;\">Total T3&nbsp;</span></p>"
      },
      {
        "id": 203330,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroid scan&nbsp;</span></p>"
      },
      {
        "id": 203331,
        "text": "<p><span style=\"font-size:12.0pt;\">Free T4&nbsp;</span></p>"
      },
      {
        "id": 203332,
        "text": "<p><span style=\"font-size:12.0pt;\">TSH&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female patient presents with weight loss, anxiety, tachycardia, and restlessness. The resting pulse was 110 beats per minute. Which of the following tests should be done next to evaluate her condition further? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023</span><span style=\"font-size:12.0pt;\">)</span></p>",
    "unique_key": "Q4137222",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320622,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TSH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">In the evaluation of suspected thyroid dysfunction, the initial and most crucial test is the measurement of Thyroid-Stimulating Hormone (TSH). TSH is the most sensitive indicator of thyroid function because even minor changes in thyroid hormone levels cause significant changes in TSH levels due to the feedback mechanism between the thyroid gland and the pituitary gland. Elevated or suppressed TSH levels provide clear insight into whether the thyroid gland is underactive (hypothyroidism) or overactive (hyperthyroidism). Given the patient's symptoms of weight loss, anxiety, tachycardia, and restlessness, hyperthyroidism is suspected, making TSH the appropriate initial test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. &nbsp;Total T3:</strong>&nbsp;T3 levels can be influenced by various factors and are usually measured after initial TSH and Free T4 tests suggest hyperthyroidism.</span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &nbsp;Thyroid Scan:&nbsp;</strong>This imaging test evaluates thyroid structure and function, useful in cases where nodules or hyperactivity need to be assessed. It is not the first-line test for evaluating general thyroid function.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Free T4:&nbsp;</strong>Free T4 is important in assessing thyroid function and is typically measured alongside TSH. However, TSH is preferred as the initial screening test due to its sensitivity in detecting thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial test for evaluating suspected thyroid dysfunction, particularly in hyperthyroid symptoms, is TSH due to its sensitivity and reliability in reflecting thyroid status.</span></p>",
    "correct_choice_id": 203332,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 20351,
    "choices": [
      {
        "id": 81365,
        "text": "<p><span style=\"font-size:18px;\">Measles vaccine</span></p>"
      },
      {
        "id": 81366,
        "text": "<p><span style=\"font-size:18px;\">Rotavirus vaccine</span></p>"
      },
      {
        "id": 81367,
        "text": "<p><span style=\"font-size:18px;\">TT/Td vaccine</span></p>"
      },
      {
        "id": 81368,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis B vaccine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>In a 10-year-old school child, which of the following vaccines is given as a part of the school immunization program?</strong><i><strong> [NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q3381513",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320328,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) TT/Td vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In the national immunization schedule, the TT/Td vaccine is given to children at 10 years &amp; 16 years of age as part of the school immunization program.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Age Limits for Delayed Immunization in NIS, India</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100004.png\" alt=\"\" width=\"1000\" height=\"713\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A</strong>.&nbsp;<strong>Measles Vaccine&nbsp;</strong>can be given till 5 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Rotavirus vaccines&nbsp;</strong>can be given till 12 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Hepatitis B vaccine&nbsp;</strong>can be given till 1 year of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>National Immunisation schedule (2023-24):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-095933.png\" alt=\"\" width=\"1000\" height=\"445\"></strong></span></p>",
    "correct_choice_id": 81367,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57596,
    "choices": [
      {
        "id": 229753,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done routinely after 24 weeks POG</span></p>"
      },
      {
        "id": 229754,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case</span></p>"
      },
      {
        "id": 229755,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case only if it threatens the life of the mother</span></p>"
      },
      {
        "id": 229756,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case with 1 Doctor\u2019s opinion only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presented to your hospital emergency with pregnancy 22 weeks, which was a result of rape. Correct statement regarding Medical Termination of Pregnancy is? (NEET PG 2024)</span></p>",
    "unique_key": "Q5642981",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320325,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) MTP is permissible for 20-24 weeks POG in this case</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the Medical Termination of Pregnancy (MTP) Act of India, MTP is permitted up to 24 weeks of pregnancy. For gestation periods from 0 to 20 weeks, it is considered low risk and only one doctor\u2019s opinion is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, for gestation periods from 20 to 24 weeks, it is categorized as high risk, and the approval of two doctors is required. This high-risk category includes specific situations such as <strong>rape, incest, disability, and when the woman is a minor</strong>. Since the woman in the question is 22 weeks pregnant due to rape, MTP is permissible under these regulations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MTP can be done routinely after 24 weeks POG:</strong> This is incorrect because MTP after 24 weeks is not routinely allowed. It requires a medical board's approval and is only permitted in exceptional cases involving severe fetal anomalies or conditions that endanger the mother\u2019s life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. MTP is permissible for 20-24 weeks POG in this case only if it threatens the life of the mother:</strong> This statement is incorrect. For 20-24 weeks POG, MTP is permitted not only for life-threatening conditions but also for cases involving rape, incest, disability, and minors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MTP is permissible for 20-24 weeks POG in this case with 1 Doctor\u2019s opinion only:</strong> This is incorrect because two doctors' opinions are required for high-risk cases between 20-24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MTP between 20-24 weeks of pregnancy is considered high risk and requires two doctors' opinions, especially in cases of rape, incest, disability, or if the woman is a minor.</span></p>",
    "correct_choice_id": 229754,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 57579,
    "choices": [
      {
        "id": 229685,
        "text": "<p><span style=\"font-size:18px;\">2-1-4-3</span></p>"
      },
      {
        "id": 229686,
        "text": "<p><span style=\"font-size:18px;\">2-4-1-3</span></p>"
      },
      {
        "id": 229687,
        "text": "<p><span style=\"font-size:18px;\">4-2-1-3</span></p>"
      },
      {
        "id": 229688,
        "text": "<p><span style=\"font-size:18px;\">4-1-2-3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>To study the effect of Vitamin C consumption on the occurrence of Respiratory disease, arrange the steps of a case-control study in sequence. </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p><br><span style=\"font-size:18px;\"><strong>1 \u2013 Measurement of exposure.</strong></span><br><span style=\"font-size:18px;\"><strong>2 \u2013 Matching.</strong></span><br><span style=\"font-size:18px;\"><strong>3 \u2013 Analysis and interpretation.</strong></span><br><span style=\"font-size:18px;\"><strong>4 \u2013 Selection of cases and controls.</strong></span></p>",
    "unique_key": "Q4124249",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320315,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 4-2-1-3</strong></span></p><p><span style=\"font-size:18px;\"><strong>&nbsp;</strong></span><br><span style=\"font-size:18px;\">A case-control study is a retrospective observational study design commonly used to investigate the causes of a condition or disease. The steps are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>4. Selection of cases and controls :</strong> The first step involves identifying the cases (individuals with the disease) and controls (individuals without the disease). In this example, cases would be people with respiratory disease, and controls would be those without it.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. Matching :</strong> The next step is to match the cases and controls on various confounding factors such as age, gender, or lifestyle to minimize bias.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. Measurement of exposure :</strong> After matching, the history of exposure to the risk factor (in this case, Vitamin C consumption) is measured for both cases and controls by collecting historical data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. Analysis and interpretation :</strong> Finally, data is analyzed, often using a 2x2 table to calculate the odds ratio, which determines the association between the exposure and the disease. An odds ratio greater than 1 indicates a positive association, less than 1 indicates a protective effect, and equal to 1 indicates no association.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">The correct sequence of steps in a case-control study is: Selection of cases and controls, matching, measurement of exposure, and then analysis and interpretation.</span></p>",
    "correct_choice_id": 229687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 24774,
    "choices": [
      {
        "id": 99057,
        "text": "<p><span style=\"font-size:11.0pt;\">Obesity hypoventilation syndrome</span></p>"
      },
      {
        "id": 99058,
        "text": "<p><span style=\"font-size:11.0pt;\">Obstructive sleep apnea</span></p>"
      },
      {
        "id": 99059,
        "text": "<p><span style=\"font-size:11.0pt;\">Central sleep apnea</span></p>"
      },
      {
        "id": 99060,
        "text": "<p><span style=\"font-size:11.0pt;\">Narcolepsy</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A female presented with excessive daytime sleepiness and impaired concentration and memory for one year. On examination the BMI was 43 kg/m\u00b2 and BP was 170/98 mmHg. ABG was done in awake state and the findings are given below. Which of the following is the likely diagnosis? PaO2: 70 mmHg PaCO2: 53 mmHg HCO3: 33 mmHg. (INICET MAY 2023)</span></p>",
    "unique_key": "Q9899699",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320614,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Obesity hypoventilation syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Obesity hypoventilation syndrome (OHS), </strong>also known as Pickwickian syndrome, is characterized by obesity (BMI &gt;30 kg/m\u00b2), hypoventilation (PaCO2 &gt;45 mmHg), and lack of significant underlying lung disease. The ABG findings showing hypercapnia (high PaCO2) and hypoxemia (low PaO2) in the awake state are indicative of OHS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Obstructive sleep apnea:</strong> Occurs during sleep, not necessarily presenting with hypercapnia in the awake state.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Central sleep apnea:</strong> Characterized by pauses in breathing during sleep without the obesity-related hypoventilation.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Narcolepsy:</strong> Does not typically present with ABG abnormalities or obesity hypoventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obesity hypoventilation syndrome involves obesity, chronic hypercapnia, and hypoxemia, primarily in the awake state.</span></p>",
    "correct_choice_id": 99057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 11079,
    "choices": [
      {
        "id": 44282,
        "text": "<p><span style=\"font-size:18px;\">y=10-\u0445</span></p>"
      },
      {
        "id": 44283,
        "text": "<p><span style=\"font-size:18px;\">x=10+\u0443</span></p>"
      },
      {
        "id": 44284,
        "text": "<p><span style=\"font-size:18px;\">y=11+2x</span></p>"
      },
      {
        "id": 44285,
        "text": "<p><span style=\"font-size:18px;\">x=11+2y</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>In a clinical study exploring the relationship between variables X and Y, a scatter plot with a linear regression line has been generated. Based on the graphical representation provided, which of the following equations corresponds to the linear regression model of the plotted graph? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip13.jpg\" alt=\"\" width=\"400\" height=\"258\"></strong></span></p>",
    "unique_key": "Q8065377",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320618,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) y=11+2x</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Y = 11 + 2x is a simple linear regression equation where a = 11 and b = 2 are constants and x and y are variables.</span></li><li><span style=\"font-size:18px;\">Regression is change in measurements of a variable. It provides structure of relationship between 2 quantitative variables.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Types of regressions:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Simple linear regression: Only one dependent variable and one independent variable</span></li><li><span style=\"font-size:18px;\">Multiple linear regression: Only one dependent variable and more than one independent variable</span></li><li><span style=\"font-size:18px;\">Simple curvilinear regression: Only one dependent variable and one independent variable, with some power of independent variable</span></li><li><span style=\"font-size:18px;\">Multiple curvilinear regression: Only one dependent variable and more than one independent variables, with some power of independent variables).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Types of regression equations:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-125240.jpg\" alt=\"\" width=\"700\" height=\"286\"></span></p>",
    "correct_choice_id": 44284,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 57585,
    "choices": [
      {
        "id": 229709,
        "text": "<p><span style=\"font-size:18px;\">Transition from infectious pandemic diseases to man-made diseases</span></p>"
      },
      {
        "id": 229710,
        "text": "<p><span style=\"font-size:18px;\">Transition from low literacy levels to high literacy levels</span></p>"
      },
      {
        "id": 229711,
        "text": "<p><span style=\"font-size:18px;\">Transition from high birth rate &amp; death rate to low birth rate &amp; death rate</span></p>"
      },
      {
        "id": 229712,
        "text": "<p><span style=\"font-size:18px;\">Transition from unfavorable sex ratio to favorable sex ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>What is demographic transition as a country passes through the demographic cycle? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q5900310",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320321,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Transition from high birth rate &amp; death rate to low birth rate &amp; death rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173804.jpg\" alt=\"\" width=\"400\" height=\"340\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The demographic transition refers to the shift in a country\u2019s population characteristics as it moves through different stages of the demographic cycle. The cycle typically includes five stages, starting with high birth and death rates (Stage 1), followed by declining death rates (Stage 2), declining birth rates (Stage 3), and eventually both low birth and death rates (Stage 4). This process reflects changes in a society\u2019s economic and social conditions, such as improvements in healthcare, education, and overall living standards. The transition leads to slower population growth and ultimately stabilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Transition from infectious pandemic diseases to man-made diseases:</strong> This option describes the <strong>epidemiological transition</strong>, which refers to the shift in the types of prevalent diseases from infectious to chronic, non-communicable diseases as a society develops.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Transition from low literacy levels to high literacy levels:</strong> This option reflects educational and social changes within a population but does not specifically describe demographic transition.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Transition from unfavorable sex ratio to favorable sex ratio:</strong> This option describes changes in gender ratios, often due to social or policy influences, but it is not directly related to demographic transition.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Demographic transition is characterized by the shift from high birth and death rates to low birth and death rates as a country progresses through the stages of the demographic cycle.</span></p>",
    "correct_choice_id": 229711,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9707,
    "choices": [
      {
        "id": 38795,
        "text": "<p><span style=\"font-size:18px;\">Dense regular</span></p>"
      },
      {
        "id": 38796,
        "text": "<p><span style=\"font-size:18px;\">Dense irregular</span></p>"
      },
      {
        "id": 38797,
        "text": "<p><span style=\"font-size:18px;\">Loose regular</span></p>"
      },
      {
        "id": 38798,
        "text": "<p><span style=\"font-size:18px;\">Loose irregular</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">What type of connective tissue is found in the region indicated by the black arrow in the provided image? (AIIMS May 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13495.jpg\" alt=\"\" width=\"300\" height=\"382\"></span></p>",
    "unique_key": "Q9266415",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320619,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Dense irregular</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In<strong>&nbsp;</strong>the provided image, the black arrow points to a region with a <strong>meshwork of collagen fibers</strong>. This pattern is characteristic of <strong>dense irregular connective tissue, </strong>which is identified by its densely packed<strong> collagen </strong>fibers that are arranged in an <strong>irregular, haphazard </strong>fashion. This type of connective tissue provides <strong>strength and support </strong>and allows the skin to <strong>resist multidirectional </strong>forces. It is typically found in areas that require <strong>strength and rigidity</strong>, such as the <strong>dermis</strong> of the skin, which is what is likely being shown in this histological slide.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Dermis (precisely Reticular dermis)&nbsp;</strong>is made up of <strong>dense irregular connective tissue.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Irregular connective tissue,&nbsp;</strong>is characterized by <strong>collagen fibers</strong> that are <strong>randomly oriented</strong> in multiple directions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Irregular connective tissue&nbsp;</strong>is of three types: <strong>Loose, Dense &amp; Adipose</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Dense&nbsp;</strong>connective tissue can be found in areas where <strong>unsheathed organs </strong>are protected and where there is significant <strong>mechanical stress.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">This arrangement of fibers provides <strong>strength and elasticity </strong>in multiple directions, allowing the skin to <strong>resist tearing.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Function: Provides <strong>structural integrity </strong>and <strong>support</strong> for the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Dense connective tissue:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">It typically exists in the <strong>reticular dermis</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Muscle and nerve sheaths&nbsp;</strong>made of the <strong>superficial</strong> connective tissue</span></li><li><span style=\"font-size:18px;\">Adventitia of <strong>large vessels</strong></span></li><li><span style=\"font-size:18px;\"><strong>Capsules</strong> of various organs &amp; glands (e.g.: testis sclera, periosteum, perichondrium)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Dense regular connective tissue</strong> features <strong>collagen fibers</strong> that are <strong>parallel</strong> to each other, conferring <strong>tensile strength</strong> in one particular direction. It is typically found in <strong>tendons and ligaments</strong>, where the force is exerted in a <strong>single direction as shown in the image below</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture72221.jpg\" alt=\"\" width=\"700\" height=\"306\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">This is not what we see in the image, where the fibers are not arranged in parallel.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Irregular and Regular connective tissue</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-195526.png\" alt=\"\" width=\"1000\" height=\"559\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C</strong>. <strong>Loose regular connective tissue</strong> is not a recognized classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Loose irregular connective tissue&nbsp;</strong>is also not a recognized classification. What is commonly known is <strong>loose connective </strong>tissue (also termed <strong>areolar connective tissue</strong>), which has a much <strong>looser fiber </strong>arrangement and a lot of <strong>ground substance</strong>, often found <strong>beneath epithelial layers</strong>, surrounding <strong>blood vessels</strong>, and <strong>nerves</strong>. It has a different appearance from what is indicated by the arrow in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The image shows <strong>dense irregular</strong> connective tissue, which is characterized by a dense network of <strong>collagen fibers</strong> arranged in an <strong>irregular</strong> pattern, commonly found in the d<strong>ermis</strong> of the skin, providing <strong>strength</strong> and the ability to resist <strong>multi-directional forces</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition: Volume 1 Chapter 2, Page no 2.34</strong></span></p><p><span style=\"font-size:18px;\"><strong>Grays Anatomy: The anatomical basis of clinical practice- 42<sup>nd</sup> edition- page no 40, 41</strong></span></p>",
    "correct_choice_id": 38796,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased"
    ]
  },
  {
    "id": 14927,
    "choices": [
      {
        "id": 59668,
        "text": "<p><span style=\"font-size:12.0pt;\">Paradiscal</span></p>"
      },
      {
        "id": 59669,
        "text": "<p><span style=\"font-size:12.0pt;\">Central</span></p>"
      },
      {
        "id": 59670,
        "text": "<p><span style=\"font-size:12.0pt;\">Anterior</span></p>"
      },
      {
        "id": 59671,
        "text": "<p><span style=\"font-size:12.0pt;\">Posterior</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Most common pattern of involvement of Pott\u2019s spine is: (INICET MAY 2022)</span></p>",
    "unique_key": "Q4138826",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320569,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Paradiscal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>POTT\u2019S SPINE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Like tuberculosis of the bones and joints elsewhere in the body, TB of the spine is always secondary.</span></li><li><span style=\"font-size:12.0pt;\">The tubercular spread to spine usually takes place from Lungs &gt; lymph nodes.</span></li><li><span style=\"font-size:12.0pt;\">The bacteria reach the spine via the hematogenous route, from the lungs or lymph nodes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Types of vertebral tuberculosis:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A. Paradiscal</strong>: This is the commonest type. In this, the contiguous areas of two adjacent vertebrae along with the intervening disc are affected.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/7_Q93okLV.jpg\" alt=\"\" width=\"500\" height=\"272\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B. Central</strong><i>:</i> In this type, the body of a single vertebra is affected. This leads to early collapse of the weakened vertebra. The nearby disc may be normal. The collapse may be a \u2018wedging\u2019 or \u2018concertina\u2019 collapse; wedging being more common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C. Anterior</strong><i>:</i> In this type, infection is localised to the anterior part of the vertebral body. The infection spreads up and down under the anterior longitudinal ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D. Posterior</strong><i>:</i> This is the least common type. In this type, the posterior complex of the vertebra, i.e., the pedicle, lamina, spinous process and transverse process are affected.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>The paradiscal type is most common &gt; </strong>central type &gt; anterior type &gt; appendiceal type (involving pedicle, lamina, and less commonly transverse process, <strong>2nd least common is spinous process and rarest variety is synovitis of facet joints).</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical features</strong>:&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Back pain, </strong>usually minimal, is the <strong>commonest and </strong>1st symptom.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tenderness&nbsp;</strong>is the <strong>earliest sign</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Paravertebral muscle spasm resulting in stiffness in the affected region is a constant early finding. The spine is held rigid. When picking an object up from floor, there is flexion at hips and knees and the spine is in extension \u2013 <strong>Coin test</strong></span></li><li><span style=\"font-size:12.0pt;\">Earliest sign of&nbsp; neurological deficit \u2013 <strong>increased deep tendon reflexes </strong>or clonus or extensor plantar response.</span></li><li><span style=\"font-size:12.0pt;\">The prominence of 2-3 spinous process, called <strong>angular kyphosis</strong> is commonest in tuberculosis because of 2 contiguous vertebra involved with paradiscal destruction.</span></li><li><span style=\"font-size:12.0pt;\">In the thoracic region, kyphosis is most marked because of normal kyphotic curvature.</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/8_mcG1lh8.jpg\" alt=\"\" width=\"150\" height=\"345\"></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Tuberculosis is the most common cause of cold abscess.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Psoas abscess can give rise to pseudo-hip flexion deformity</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Paraplegia occurs most often in upper thoracic region.</strong>\u2219</span></li><li><span style=\"font-size:12.0pt;\">Early onset paresis is due to inflammatory edema, granulation tissue, an abscess, caseous material. It has good prognosis.</span></li><li><span style=\"font-size:12.0pt;\">Late onset paresis is due to increasing deformity or reactivation of disease, bony sequestrum, stenosis of the vertebral canal, fibrosis or vascular insufficiency and has poor prognosis.</span></li><li><span style=\"font-size:12.0pt;\">Sequelae of TB spine is usually bony ankylosis.</span></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Imaging:</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Plain radiograph:&nbsp;</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Earliest X-ray feature is loss of Curvature due to paravertebral spasm.</strong></span></li><li><span style=\"font-size:12.0pt;\">Reduction of disc space</span></li><li><span style=\"font-size:12.0pt;\">Vertebral body destruction</span></li><li><span style=\"font-size:12.0pt;\">Paravertebral abscess appears as fusiform shadows along vertebral column.</span></li><li><span style=\"font-size:12.0pt;\">Widening of mediastinum</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>CT scan:</strong></span><span style=\"font-size:11pt;\">&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">It may detect a small paravertebral abscess, not otherwise seen on plain X-ray; may indicate precisely the extent of destruction of the vertebral body and posterior elements; and may show a sequestrum or a bony ridge pressing on the cord.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>MRI</strong>:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Investigation of choice</strong> to evaluate the type and extent of compression of the cord.</span></li><li><span style=\"font-size:12.0pt;\">It also shows condition of the underlying neural tissues, and thus helps in predicting the prognosis in a particular case.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/9_vultMKm.jpg\" alt=\"\" width=\"500\" height=\"325\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Biopsy:</strong></span><ul><li><span style=\"font-size:12.0pt;\">CT guided needle biopsy, or an open biopsy may be required in a case with doubtful diagnosis.</span></li></ul></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Stages of TB Spine with Neural Deficit:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Stage 1:&nbsp;</strong>no neural complaint; increased reflexes</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 2:&nbsp;</strong>weakness but can walk with support</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 3:&nbsp;</strong>non-ambulatory or has sensory loss &lt;50%</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 4:&nbsp;</strong>bowel/bladder involvement or sensory loss &gt;50%</span><br>&nbsp;<br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Middle path regimen is used in India</strong></span></li><li><span style=\"font-size:12.0pt;\">Treatment is done with antitubercular therapy (ATT), spinal brace and rest.</span></li><li><span style=\"font-size:12.0pt;\">Patient is followed on with complete neural examination and if progress is good then continued on non-operative management but if indications of surgery exists &nbsp;then, surgery needs to be done.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage-wise Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Stage 1</strong>: ATT + rest + monthly neural examination</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 2</strong>: ATT + rest + weekly neural examination</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 3</strong>: ATT + rest + daily neural examination</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 4</strong>: ATT + Decompression and bone grafting</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>ATT</strong>:&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Rifampicin is always a part of all regimens.</span></li><li><span style=\"font-size:12.0pt;\">Minimum duration is 9-12 months in spinal TB and may be given up to 18-24 months depending upon clinical, radiological (MRI) and hematological (ESR) healing (in non-spinal TB the duration of ATT is 6 months-1 year).</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Indications of surgery</strong>:&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Bowel bladder involvement</span></li><li><span style=\"font-size:12.0pt;\">Deterioration in neural or clinical status on treatment</span></li><li><span style=\"font-size:12.0pt;\">No improvement in neural or clinical status after conservative trial of 3-4 weeks</span><br>&nbsp;</li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\">Surgical options for most of the cases aren anterior decompression + bone grafting or anterolateral decompression + bone grafting and both have similar success rates.</span></li><li><span style=\"font-size:12.0pt;\">Hong Kong operation is also carried out.</span></li><li><span style=\"font-size:12.0pt;\">Structures removed in anterolateral decompression are part of rib, one side transverse process, one pedicle and small part of vertebral body (intercostal nerves are exposed)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/10_PADr1go.jpg\" alt=\"\" width=\"500\" height=\"307\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Structures removed in anterolateral decompression</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Posterior structures like lamina are never removed in tuberculosis because disease destroys anteriorly and if surgeon destroys posteriorly then there will be instability.</span></li><li><span style=\"font-size:12.0pt;\">These surgeries are carried out in right lateral position (right side down and left side up) approaching the spine from left side as the vessel handled is aorta on left side which is thick muscular vessel with more resilience to handling pressure as compared to vena cava on right side which is friable to handle.</span><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Prognostic Factors:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-125724.jpg\" alt=\"\" width=\"1000\" height=\"625\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/11.jpg\" alt=\"\" width=\"600\" height=\"358\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/12.jpg\" alt=\"\" width=\"600\" height=\"328\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The paradiscal type is most common pattern of involvement followed by central type followed by anterior type followed by the posterior type. &nbsp;</span></li></ul>",
    "correct_choice_id": 59668,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 15136,
    "choices": [
      {
        "id": 60504,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 60505,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 60506,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 60507,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are true about the internal capsule?(INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Charcot's artery supplies the posterior limb.</span></li><li><span style=\"font-size:12.0pt;\">Retrolenticular part of the internal capsule contains optic radiation.</span></li><li><span style=\"font-size:12.0pt;\">Anterior limb of the capsule contains corticospinal tract fibers of the upper limb and face.</span></li><li><span style=\"font-size:12.0pt;\">Internal capsule has projection fibers.</span></li></ol><p>&nbsp;</p>",
    "unique_key": "Q4341866",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320565,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The internal capsule is primarily composed of projection fibers that connect the cortex to other parts of the brain or spinal cord. The internal capsule can be divided into three parts: anterior limb, genu, and posterior limb. Lesions in these areas can result in different neurological deficits.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The anterior limb contains fibers that connect the frontal cortex to the thalamus and basal ganglia, and lesions here can cause motor and behavioral changes. Fronto pontine fibers also pass via anterior limb.</span></li><li><span style=\"font-size:12.0pt;\">The genu contains fibers that connect the frontal cortex to the contralateral motor cortex, and lesions here can cause facial weakness and hemiparesis. Fronto pontine and cortico nuclear fibers pass via genu.</span></li><li><span style=\"font-size:12.0pt;\">The posterior limb contains fibers that connect the sensory and motor cortices to the brainstem and spinal cord, and lesions here can cause sensory and motor deficits Fronto pontine, cortico spinal fir trunk, upper as well as lower limbs via posterior limb..</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The retrolenticular part of the internal capsule carries fibers primarily from the optic radiation, which is a bundle of axons that originate from the lateral geniculate nucleus of the thalamus and terminate in the visual cortex in the occipital lobe. Lesions in this area can result in visual field deficits, such as homonymous hemianopia, superior or inferior quadrantanopia. (Parieto pontine and occipito pontine fibers also pass via retrolentiform) Charcots artery supplies the genu and posterior limb. Hence statement 1, 2 and 4 correct.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-11.jpg\" alt=\"\" width=\"700\" height=\"282\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-12.jpg\" alt=\"\" width=\"700\" height=\"439\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4</strong>: <strong>Internal capsule has projection fibers -</strong> The internal capsule contains a large collection of projection fibers that include both ascending sensory and descending motor pathways. These fibers connect the cerebral cortex with the brainstem and spinal cord, conveying sensory information to the cortex and motor commands away from the cortex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The internal capsule, a key white matter structure in the brain, contains Charcot's artery-supplied posterior limb, optic radiation in the retrolenticular part, and is primarily composed of projection fibers linking the cortex with the brainstem and spinal cord. Misinformation about the anterior limb's contents highlights the complexity and specificity of its neural pathways.</span></p>",
    "correct_choice_id": 60506,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 63633,
    "choices": [
      {
        "id": 253737,
        "text": "<p><span style=\"font-size:12.0pt;\">Tachycardia</span></p>"
      },
      {
        "id": 253738,
        "text": "<p><span style=\"font-size:12.0pt;\">Tolerance</span></p>"
      },
      {
        "id": 253739,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
      },
      {
        "id": 253740,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an adverse effect of salbutamol?</span></p>",
    "unique_key": "Q3641940",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320557,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypoglycemia</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Salbutamol, a \u03b22-adrenergic agonist, is commonly used as a bronchodilator to treat conditions like asthma and chronic obstructive pulmonary disease (COPD). It has several known side effects, but hypoglycemia is not one of them. In fact, salbutamol can cause hyperglycemia as a result of increased glycogenolysis in the liver and reduced insulin sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism</strong>: Salbutamol stimulates \u03b22 receptors in various tissues:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tachycardia</strong>: Tachycardia is a well-documented adverse effect of salbutamol. The drug can cause increased heart rate through reflex sympathetic stimulation and a direct impact on cardiac \u03b21 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tolerance</strong>: Tolerance can develop with long-term use of salbutamol, as the body becomes desensitized to the drug's effects due to receptor downregulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hypokalemia: </strong>Salbutamol causes hypokalemia by promoting the uptake of potassium into cells, particularly in the skeletal muscles, thus lowering plasma potassium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Salbutamol's adverse effects include tachycardia, hypokalemia, and the development of tolerance with prolonged use. It does not cause hypoglycemia but rather can lead to hyperglycemia.</span></p>",
    "correct_choice_id": 253740,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ]
  },
  {
    "id": 54794,
    "choices": [
      {
        "id": 218641,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 2</span></span></span></p>"
      },
      {
        "id": 218642,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 3</span></span></span></p>"
      },
      {
        "id": 218643,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 4</span></span></span></p>"
      },
      {
        "id": 218644,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">&nbsp;REM</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the stage of sleep denoted by the arrow: (INICET MAY 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-152214.png\" style=\"height:193px; width:400px\" /></p>",
    "unique_key": "Q1902247",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320561,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) REM</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The stage of sleep indicated by the arrow is REM (Rapid Eye Movement) sleep. This can be identified based on the specific patterns observed in the EEG (Electroencephalogram), EMG (Electromyogram), and EOG (Electrooculogram) readings:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/whatsapp-image-2024-08-26-at-21214-pm.jpeg\" style=\"height:220px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EEG</span></strong><span style=\"font-size:12.0pt\">: The EEG during REM sleep shows low-amplitude, high-frequency waves that are similar to the wakeful state. This pattern is characteristic of REM sleep and is often described as &quot;sawtooth&quot; waves.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EMG</span></strong><span style=\"font-size:12.0pt\">: The EMG during REM sleep shows a flat line, indicating muscle atonia. This muscle atonia is a defining feature of REM sleep, where most of the body&#39;s voluntary muscles are temporarily paralyzed. This prevents the sleeper from acting out their dreams.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EOG</span></strong><span style=\"font-size:12.0pt\">: The EOG during REM sleep shows rapid movements of the eyes, which is where REM sleep gets its name. These rapid eye movements are indicative of the intense brain activity occurring during this stage, despite the body&#39;s overall lack of movement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In contrast, non-REM (NREM) sleep stages (including NREM 2, 3, and 4) show different patterns:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NREM stages generally have higher amplitude, lower frequency EEG patterns.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Muscle tone is reduced but not absent as in REM sleep.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eye movements are either slow or absent, depending on the specific NREM stage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. NREM 2</span></strong><span style=\"font-size:12.0pt\">: This stage of sleep is characterized by sleep spindles and K-complexes on the EEG, with reduced but not absent muscle tone and minimal eye movement. The patterns described in the question do not match this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. NREM 3</span></strong><span style=\"font-size:12.0pt\">: Known as slow-wave sleep or deep sleep, NREM 3 is characterized by high-amplitude, low-frequency delta waves on the EEG. Muscle tone is decreased but not completely absent, and there is minimal to no eye movement. The pattern described does not correspond to NREM 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. NREM 4</span></strong><span style=\"font-size:12.0pt\">: Often combined with NREM 3 in the modern classification, this stage is also characterized by delta waves, reduced muscle tone, and lack of eye movement. The described pattern is inconsistent with this stage as well.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">REM sleep is characterized by low-amplitude, high-frequency EEG waves, muscle atonia as shown in the EMG, and rapid eye movements as shown in the EOG. Recognizing these patterns is crucial for correctly identifying REM sleep, which is a critical stage for processes like memory consolidation and emotional regulation.</span></span></span></p>",
    "correct_choice_id": 218644,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57595,
    "choices": [
      {
        "id": 229749,
        "text": "<p><span style=\"font-size:18px;\">Integrated Disease Surveillance Program</span></p>"
      },
      {
        "id": 229750,
        "text": "<p><span style=\"font-size:18px;\">National TB Elimination Program</span></p>"
      },
      {
        "id": 229751,
        "text": "<p><span style=\"font-size:18px;\">National Leprosy Eradication Program</span></p>"
      },
      {
        "id": 229752,
        "text": "<p><span style=\"font-size:18px;\">National Health Mission</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The given image is the logo for which of the following health programs? </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174045.jpg\" alt=\"\" width=\"400\" height=\"487\"></strong></span></p>",
    "unique_key": "Q8329922",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320324,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) National Leprosy Eradication Program</strong></span></p><p><br><span style=\"font-size:18px;\">The logo shown is for the National Leprosy Eradication Program (NLEP). The design of the logo holds significant meaning:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Sun:</strong> The sun in the center of the hand symbolizes hope and optimism, reflecting the positive outcomes of leprosy treatment.</span></li><li><span style=\"font-size:18px;\"><strong>Lotus Flower:</strong> This represents purity and beauty, indicating that there should be no stigma attached to those affected by leprosy.</span></li><li><span style=\"font-size:18px;\"><strong>Cured Thumb:</strong> The image of the healed thumb symbolizes that leprosy is a 100% curable disease. The thumb indicates that the affected person has been cured and is now a fully integrated member of society.</span></li><li><span style=\"font-size:18px;\"><strong>House-Shaped Hand:</strong> The hand shaped like a house emphasizes that the cured individual is an integral part of their family and community.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">These elements collectively reinforce the message of hope, inclusion, and the need to remove stigma associated with leprosy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Integrated Disease Surveillance Program (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174128.jpg\" alt=\"\" width=\"400\" height=\"375\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.&nbsp; National TB Elimination Program (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174151.jpg\" alt=\"\" width=\"300\" height=\"368\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp; National Health Mission (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174218.jpg\" alt=\"\" width=\"300\" height=\"244\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">The National Leprosy Eradication Program logo symbolizes hope, the curability of leprosy, and the inclusion of cured individuals into society, promoting a stigma-free approach towards the disease.</span></p>",
    "correct_choice_id": 229751,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 12875,
    "choices": [
      {
        "id": 51462,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic hypoxia</span></span></span></p>"
      },
      {
        "id": 51463,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ischemic hypoxia</span></span></span></p>"
      },
      {
        "id": 51464,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia</span></span></span></p>"
      },
      {
        "id": 51465,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Out of the options given below, what is the cause of death in smoke inhalation? (</span></span>AIIMS Nov 2018)</p>",
    "unique_key": "Q4079740",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320551,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Anemic hypoxia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Smoke contains multiple substances, of which the most significant component is carbon monoxide (CO). CO can cause both anemic hypoxia as well as histotoxic hypoxia, but predominant cause is anemic hypoxia. Mechanism of hypoxia by CO:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic Hypoxia by CO:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CO combines with hb to form COHb) producing anemic hypoxia (blood O2-carrying capacity is reduced)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic Hypoxia by CO:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While the primary impact of CO is on blood oxygen transport, the presence of COHb can also interfere with cellular respiration at the tissue level. COHb affects mitochondrial function and the electron transport chain, disrupting the cells&#39; ability to utilize the oxygen that is delivered to them.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option A)</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Histotoxic hypoxia&nbsp;</strong>occurs when cells can&rsquo;t effectively use the available oxygen </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">due to interference with crucial cellular processes. CO causes histotoxic hypoxia also but the main cause of death is anemic hypoxia. A typical example of histotoxic hypoxia is cyanide poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Ischemic hypoxia&nbsp;</span></strong><span style=\"font-size:12.0pt\">results from inadequate circulation due to conditions such as heart failure and hypoxia in the setting of shock. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) All of the above&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">it is incorrect as CO may cause anemic and histotoxic hypoxia but not ischemic hypoxia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">Anemic hypoxia is hypoxia&nbsp; caused by the decreased O<sub>2</sub>-carrying capacity of blood. It can occur due to two reasons: </span></span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">Hb concentration is low, or</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">Hb concentration may be normal, but it is not able to bind to O2. It can occur due to following conditions:</span></span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">CO Poisoning: It has a higher affinity for Hb than O2 forming COHb.</span></span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">Methemoglobinemia: Methemoglobin is a form of Hb where the iron is in the ferric state (Fe3+) instead of the normal ferrous state (Fe2+). Methemoglobin cannot bind to oxygen effectively.</span></span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"color:#202124\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\">Certain Genetic Hemoglobin Disorders altering the structure of Hb, e.g. </span></span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:144px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202124\">Sickle cell anemia, thalassemia.</span></span></span></span></span></p>",
    "correct_choice_id": 51464,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 7096,
    "choices": [
      {
        "id": 28352,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gs</span></span></span></p>"
      },
      {
        "id": 28353,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gi</span></span></span></p>"
      },
      {
        "id": 28354,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gq</span></span></span></p>"
      },
      {
        "id": 28355,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Go</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phospholipase C acts via which of the following G protein-coupled receptors?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q1289577",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320562,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Gq&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phospholipase C acts via the Gq type of G protein-coupled receptors. It leads to the activation of the IP3-DAG pathway. The receptors that act via this pathway include the receptors of H1, &alpha;1, M1, V1, M3, Angiotensin II, Gastrin, GnRH, Oxytocin and TRH.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Important points about GPCR:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G protein-coupled receptors (GPCRs) are cell membrane receptors that span across the membrane 7 times (heptahelical). Subtypes of GPCRs are distinguished by their alpha subunits. The important subtypes of GPCRs are Gs, Gp, Gq, and Go. GPCRs act via various second messengers. The important ones with their action on the effector are:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gs causes activation of adenylyl cyclase and thus increase in cAMP.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gi causes inhibition of adenylyl cyclase and thus decrease in cAMP.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Go causes Ca2+ channel inhibition.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gq causes activation of phospholipase C which generates the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). It helps in mobilizing Ca<sup>2+</sup> form the endoplasmic reticulum stores.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phospholipase C (PLC) is activated by Gq-coupled receptors, which in turn generate the second messengers IP3 and DAG, leading to various downstream effects, including the mobilization of calcium ions from intracellular stores.</span></span></span></p>",
    "correct_choice_id": 28354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 5810,
    "choices": [
      {
        "id": 23210,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At the onset of labor</span></span></span></p>"
      },
      {
        "id": 23211,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">34 weeks</span></span></span></p>"
      },
      {
        "id": 23212,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36 weeks</span></span></span></p>"
      },
      {
        "id": 23213,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">40 weeks</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised?&nbsp;</span></span>(INICET MAY 2018)</p>",
    "unique_key": "Q8889904",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320549,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 36 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of anticoagulation in pregnant women with cardiac disease involves switching from warfarin to heparin at specific times to minimize the risk of complications to the fetus and to prepare for delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to Heparin at 36 Weeks:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> According to guidelines from the American College of Chest Physicians, pregnant women on warfarin therapy should switch to heparin at 36 weeks of gestation. This is done to reduce the risk of bleeding complications during labor and delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guidelines Summary:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early Pregnancy (up to 12 weeks):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue warfarin as soon as pregnancy is diagnosed, especially if the warfarin dose is &gt;5mg/day, due to the risk of warfarin embryopathy.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replace with heparin (5,000 units twice daily subcutaneously) or low molecular weight heparin (LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 12 Weeks to 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin can be resumed after the 12th week and continued up to 36 weeks.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch from warfarin to heparin (either unfractionated or LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Just Before Delivery:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue heparin just before delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restart heparin (unfractionated or LMWH) 6 hours after vaginal delivery and 24 hours after cesarean section.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin therapy can also be safely resumed during breastfeeding.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The final switch from warfarin to heparin in pregnant women with cardiac disease is advised at 36 weeks of gestation to minimize the risk of bleeding complications during labor and delivery.</span></span></span></p>",
    "correct_choice_id": 23212,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20352,
    "choices": [
      {
        "id": 81369,
        "text": "<p><span style=\"font-size:18px;\">Help with PET scan units for diagnosis of cancer</span></p>"
      },
      {
        "id": 81370,
        "text": "<p><span style=\"font-size:18px;\">Human resource strengthening</span></p>"
      },
      {
        "id": 81371,
        "text": "<p><span style=\"font-size:18px;\">Setting up chemotherapy units</span></p>"
      },
      {
        "id": 81372,
        "text": "<p><span style=\"font-size:18px;\">Setting up cobalt therapy units</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the following statements is true about cancer treatment according to the Colombo plan? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q7099148",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320329,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Setting up cobalt therapy units</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Colombo Plan, established in 1950, was drawn up for the cooperative economic development of South and South-East Asia. It included 20 countries with the main aim of improving the living standards of people. The plan focused on industrial and agricultural development and provided support for health promotion, mostly through fellowships.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Key Contributions of the Colombo Plan:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>AIIMS, New Delhi:&nbsp;</strong>Established with financial assistance from New Zealand.</span></li><li><span style=\"font-size:18px;\"><strong>Cobalt Therapy Units:&nbsp;</strong>Canada supplied cobalt therapy units to medical institutions in India as part of the Colombo Plan. These units significantly enhanced the capabilities for cancer treatment in India.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Cobalt Therapy Units:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Cobalt Therapy:&nbsp;</strong>Involves using gamma rays from cobalt-60 isotopes to treat cancer. It was a crucial development in radiotherapy in the mid-20th century and improved cancer treatment outcomes significantly.</span></li><li><span style=\"font-size:18px;\"><strong>Provision under Colombo Plan:&nbsp;</strong>The supply of cobalt therapy units by Canada helped Indian medical institutions upgrade their cancer treatment facilities, making advanced radiotherapy accessible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Under the Colombo Plan, Canada supplied cobalt therapy units to medical institutions in India, significantly enhancing the country's capacity to provide advanced cancer treatment through radiotherapy. This was a crucial step in improving healthcare infrastructure and cancer treatment capabilities in India.</span></p>",
    "correct_choice_id": 81372,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 20355,
    "choices": [
      {
        "id": 81381,
        "text": "<p><span style=\"font-size:18px;\">Collect water from already leaking taps</span></p>"
      },
      {
        "id": 81382,
        "text": "<p><span style=\"font-size:18px;\">Before collecting, let water flow for at least 1 minute</span></p>"
      },
      {
        "id": 81383,
        "text": "<p><span style=\"font-size:18px;\">Water sample container is kept close to the tap avoid spillage</span></p>"
      },
      {
        "id": 81384,
        "text": "<p><span style=\"font-size:18px;\">Collect from a gentle stream of water to avoid splashing</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>How is water collected for bacteriological examination during a disease outbreak? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q1903602",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320332,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Collect from a gentle stream of water to avoid splashing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">When collecting water for bacteriological examination, especially during a disease outbreak, it is crucial to follow proper procedures to avoid contamination and ensure the sample's accuracy. The best practice is to collect water from a gentle stream to avoid splashing, which can introduce contaminants from the environment into the sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Collect water from already leaking tape:&nbsp;</strong>Not recommended as it could contaminate the sample and may lead to false results.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Before collecting, let water flow for at least 1 minute</strong>: Before collecting, let water flow for at least 2 minutes</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Water sample container is kept close to the tap to avoid spillage:&nbsp;</strong>It is a good practice but this practice alone does not ensure the proper collection of the sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">When collecting water for bacteriological examination during a disease outbreak, it is crucial to collect from a gentle stream of water to avoid splashing and potential contamination. This practice ensures the accuracy and reliability of the water sample.</span></p>",
    "correct_choice_id": 81384,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57580,
    "choices": [
      {
        "id": 229689,
        "text": "<p><span style=\"font-size:18px;\">Disaster impact \u2013 Mitigation \u2013 Rehabilitation \u2013 Response</span></p>"
      },
      {
        "id": 229690,
        "text": "<p><span style=\"font-size:18px;\">Disaster impact \u2013 Response \u2013 Rehabilitation \u2013 Mitigation</span></p>"
      },
      {
        "id": 229691,
        "text": "<p><span style=\"font-size:18px;\">Rehabilitation \u2013 Response \u2013 Disaster impact \u2013 Mitigation</span></p>"
      },
      {
        "id": 229692,
        "text": "<p><span style=\"font-size:18px;\">Response \u2013 Disaster impact \u2013 Rehabilitation \u2013 Mitigation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Arrange the steps of the Disaster cycle in sequence.</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q6403048",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320316,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Disaster impact \u2013 Response \u2013 Rehabilitation \u2013 Mitigation&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The disaster cycle outlines the sequential steps taken in response to a disaster and how communities can prepare and recover from such events. The correct sequence is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Disaster Impact</strong>: This is the immediate occurrence of the disaster event, such as an earthquake, flood, or hurricane, leading to direct damage and disruption.</span></li><li><span style=\"font-size:18px;\"><strong>Response</strong>: Following the impact, emergency measures are taken to save lives, provide first aid, conduct search and rescue, and offer immediate relief such as food, shelter, and medical treatment.</span></li><li><span style=\"font-size:18px;\"><strong>Rehabilitation</strong>: After the initial response, efforts shift to restoring essential services and helping affected communities return to normal. This involves rebuilding infrastructure, ensuring public health, and restoring social and economic activities.</span></li><li><span style=\"font-size:18px;\"><strong>Mitigation</strong>: This final step involves implementing measures to reduce the severity of future disasters. This can include building stronger infrastructure, improving disaster preparedness plans, and promoting community awareness to minimize potential damage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The correct sequence of the disaster cycle is: Disaster Impact \u2192 Response \u2192 Rehabilitation \u2192 Mitigation.</span></p>",
    "correct_choice_id": 229690,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 73234,
    "choices": [
      {
        "id": 291893,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">1, 2, 3</span></p>"
      },
      {
        "id": 291894,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 291895,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">2 only</span></p>"
      },
      {
        "id": 291896,
        "text": "<p><span style=\"font-size:16px;\">3 &amp; 4 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following transport mechanism doesn\u2019t require ATP: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qCr6vVp.png\" width=\"1174\" height=\"637\"></span></p>",
    "unique_key": "Q3699429",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320566,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>The image shows four different transport mechanisms across cell membranes:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Simple diffusion through membrane:&nbsp;</strong>This shows direct diffusion of molecules through the lipid bilayer from high concentration to low concentration. This is also passive transport that doesn't require ATP.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Simple diffusion through channels</strong>: This shows molecules moving through a protein channel from high concentration to low concentration. This is passive transport that follows the concentration gradient without requiring ATP. Channels have gates that simply open or close without configurational changes, allowing molecules to pass according to their concentration gradient.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Paracellular transport:&nbsp;</strong>This shows molecules moving between cells through the spaces between adjacent cells, not through the cells themselves. This is passive movement along the concentration gradient and doesn't require ATP.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Active transport:&nbsp;</strong>This shows fewer molecules on one side and more on the other side, indicating movement against the concentration gradient (from low to high concentration). This requires energy in the form of ATP to power the transport proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Simple diffusion through membrane</strong>,<strong> Simple diffusion through channels, Paracellular transport</strong> do not require ATP as they represent forms of passive transport, while <strong>Active transport</strong> requiring ATP&nbsp;</span></p>",
    "correct_choice_id": 291893,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 20349,
    "choices": [
      {
        "id": 81357,
        "text": "<p><span style=\"font-size:18px;\">Green</span></p>"
      },
      {
        "id": 81358,
        "text": "<p><span style=\"font-size:18px;\">Red</span></p>"
      },
      {
        "id": 81359,
        "text": "<p><span style=\"font-size:18px;\">Grey</span></p>"
      },
      {
        "id": 81360,
        "text": "<p><span style=\"font-size:18px;\">Yellow</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A 22-year-old female comes to the STI clinic with minimal vaginal discharge. On speculum examination, erosions are seen on the cervix. Which of the following kit should be given to this patient? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q1668333",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320326,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Grey</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The patient presents with erosions on the cervix, which is indicative of cervicitis. According to the syndromic management guidelines for sexually transmitted infections (STIs), cervicitis is treated with the Grey Kit (Kit 1).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>STI color coded kits:&nbsp;</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-095220.png\" alt=\"\" width=\"1000\" height=\"349\"></span></p>",
    "correct_choice_id": 81359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 9789,
    "choices": [
      {
        "id": 39123,
        "text": "<p><span style=\"font-size:12.0pt;\">Amorphous densities in mitochondria</span></p>"
      },
      {
        "id": 39124,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell membrane blebs and loss of microvilli</span></p>"
      },
      {
        "id": 39125,
        "text": "<p><span style=\"font-size:12.0pt;\">Ribosomal detachment from endoplasmic reticulum</span></p>"
      },
      {
        "id": 39126,
        "text": "<p><span style=\"font-size:12.0pt;\">Nuclear changes like pyknosis and karyolysis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which is the most important light microscopic feature of irreversible cell injury?</span> (AIIMS MAY 2019)</p>",
    "unique_key": "Q4927503",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320559,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Nuclear changes like pyknosis and karyolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most important light microscopic features of <strong>irreversible cell injury</strong> are <strong>nuclear changes</strong>. These changes are indicative of cell death and include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pyknosis</strong>: The nucleus shrinks and becomes dense, with chromatin condensing into a solid, darkly staining mass.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Karyorrhexis</strong>: The pyknotic nucleus fragments into smaller pieces.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Karyolysis</strong>: The nuclear fragments dissolve and fade, leading to the eventual loss of the nucleus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These nuclear changes are hallmark signs of irreversible cell damage and cell death, distinguishing them from reversible changes such as cellular swelling or detachment of ribosomes from the endoplasmic reticulum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Amorphous densities in mitochondria</strong>: These changes are often seen in irreversible cell injury, particularly in the context of mitochondrial dysfunction, but nuclear changes are more definitive indicators of irreversible damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Cell membrane blebs and loss of microvilli</strong>: These features are associated with reversible cell injury, not irreversible injury. They indicate cellular swelling and loss of structural integrity but do not signify cell death.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Ribosomal detachment from endoplasmic reticulum</strong>: This is also a feature of reversible cell injury, indicating disruption in protein synthesis, but it does not define irreversible injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyknosis, karyorrhexis, and karyolysis on light microscopy are signs of irreversible cell injury.</span></p>",
    "correct_choice_id": 39126,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 10280,
    "choices": [
      {
        "id": 41086,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum potassium</span></p>"
      },
      {
        "id": 41087,
        "text": "<p><span style=\"font-size:12.0pt;\">\u0421\u0412\u0421</span></p>"
      },
      {
        "id": 41088,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum chloride</span></p>"
      },
      {
        "id": 41089,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum calcium</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">After the delivery of an infant of a diabetic mother, the blood glucose of the Infant was 60 mg/dl. Which other investigation would you do? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q2396022",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320620,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Serum calcium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In infants born to diabetic mothers, it is essential to assess the serum calcium level to rule out hypocalcemia. Infants of diabetic mothers are predisposed to conditions like hypoglycemia, hypocalcemia, and hypomagnesemia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypocalcemia&nbsp;</strong>is defined as a total serum calcium level below 8 mg/dL in term infants and below 7 mg/dL in preterm infants. This condition often occurs due to lower levels of parathyroid hormone (PTH) in infants of diabetic mothers. In utero, the higher levels of maternal serum ionized calcium may suppress the fetal parathyroid glands, leading to hypocalcemia after birth. If untreated, hypocalcemia can result in neurological symptoms, including seizures, headaches, and neurological deficits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum potassium</strong>: Serum potassium is not directly related to hypoglycemia in infants of diabetic mothers. The primary concern in this scenario is hypocalcemia rather than potassium imbalance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CBC</strong>: While a complete blood count (CBC) can provide useful information, it is not specifically related to the metabolic risks associated with infants of diabetic mothers. Serum calcium is a more appropriate investigation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum chloride</strong>: Serum chloride levels do not have a direct connection with hypoglycemia or the other metabolic issues typically seen in infants of diabetic mothers. Therefore, it is not the most relevant test in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In infants of diabetic mothers, it is crucial to monitor serum calcium levels alongside blood glucose to detect and manage hypocalcemia, which can have significant neurological implications if untreated.</span></p>",
    "correct_choice_id": 41089,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 57582,
    "choices": [
      {
        "id": 229697,
        "text": "<p><span style=\"font-size:18px;\">09</span></p>"
      },
      {
        "id": 229698,
        "text": "<p><span style=\"font-size:18px;\">18</span></p>"
      },
      {
        "id": 229699,
        "text": "<p><span style=\"font-size:18px;\">50</span></p>"
      },
      {
        "id": 229700,
        "text": "<p><span style=\"font-size:18px;\">100</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>In a community, there were 550 births in a year out of which 50 were stillbirths. There were 09 deaths among newborns during 0-7 days of life. An additional 41 deaths occurred during 8-28 days of life. Calculate the Early Neonatal Mortality rate for the given community. </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q8854112",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320318,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 18</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Early Neonatal Mortality Rate (ENMR) measures the number of deaths of newborns within the first 7 days of life per 1,000 live births. It focuses specifically on early neonatal deaths, which occur during the first week of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Total births:</strong> 550</span></li><li><span style=\"font-size:18px;\"><strong>Stillbirths:</strong> 50</span></li><li><span style=\"font-size:18px;\"><strong>Live births (LB):</strong> 550 - 50 = 500</span></li><li><span style=\"font-size:18px;\"><strong>Early Neonatal Deaths (ENND):</strong> 9 deaths during 0-7 days.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>ENMR formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173647.jpg\" alt=\"\" width=\"700\" height=\"126\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Therefore, the Early Neonatal Mortality Rate is 18 deaths per 1,000 live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Early Neonatal Mortality Rate is calculated as the number of early neonatal deaths (0-7 days) per 1,000 live births.</span></p>",
    "correct_choice_id": 229698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 20350,
    "choices": [
      {
        "id": 81361,
        "text": "<p><span style=\"font-size:18px;\">Years lost to morbidity</span></p>"
      },
      {
        "id": 81362,
        "text": "<p><span style=\"font-size:18px;\">Years lost due to premature death</span></p>"
      },
      {
        "id": 81363,
        "text": "<p><span style=\"font-size:18px;\">Years lost to disability</span></p>"
      },
      {
        "id": 81364,
        "text": "<p><span style=\"font-size:18px;\">Years lost to poor quality of life</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The years of potential life lost could be attributed to? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q9672557",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320327,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Years lost due to premature death</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Years of Potential Life Lost (YPLL)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Definition: YPLL is based on Years of life lost through premature death</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Importance:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">YPLL occurs before the age to which a dying person could have expected to survive</span></li><li><span style=\"font-size:18px;\">YPLL is a type of mortality indicator</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Years lost to morbidity&nbsp;</strong>refers to the time spent living with a disease or disability, which is not directly related to the concept of years of potential life lost.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Years lost to disability&nbsp;</strong>is a component of disability-adjusted life years (DALY). DALY Is BEST measure of burden of disease in a defined population and the effectiveness of interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">DALY = YLL (Years of lost life) + YLD (Years lost to disability)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp;</strong>life would account into QALY (Quality Adjusted Life Years)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Years of Potential Life Lost (YPLL)&nbsp;</strong>is a measure that quantifies the impact of premature death on a population by calculating the number of years not lived by individuals who die before reaching a specified age. It highlights the significance of early mortality and its impact on society.</span></p>",
    "correct_choice_id": 81362,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 570,
    "choices": [
      {
        "id": 2276,
        "text": "<p><span style=\"font-size:12pt;\">0.2 Hz</span></p>"
      },
      {
        "id": 2277,
        "text": "<p><span style=\"font-size:12pt;\">2 Hz</span></p>"
      },
      {
        "id": 2278,
        "text": "<p><span style=\"font-size:12pt;\">20 Hz</span></p>"
      },
      {
        "id": 2279,
        "text": "<p><span style=\"font-size:12pt;\">50 Hz</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the frequency of tetanic stimulation used in neuromuscular monitoring? (</span>INICET Nov 2021)</p>",
    "unique_key": "Q7047513",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320546,
    "difficulty_level": "difficult",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. 50 Hz</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This is the frequency typically used for tetanic stimulation in neuromuscular monitoring. A stimulation of 50 Hz for 5 seconds results in a tetanic contraction. If the patient is under profound neuromuscular blockade, no contraction will be observed. If there's some recovery from blockade, a contraction will be noted but may be weaker than in a patient with no blockade. Fade during or after tetanic stimulation can indicate incomplete recovery from blockade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tetanic stimulation is a method used in neuromuscular monitoring to assess the degree of neuromuscular blockade in patients who have received neuromuscular blocking agents (often used during surgeries to produce muscle paralysis). Tetanic stimulation involves giving a high-frequency series of electrical impulses to a peripheral nerve to cause sustained muscle contraction. The response to tetanic stimulation can help determine the depth of neuromuscular blockade and the presence of fade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 0.2 Hz</strong>: This frequency is more representative of a \"single twitch\" stimulation, where one stimulus is delivered every 5 seconds. It is used to monitor the initial onset and the later stages of recovery from neuromuscular blockade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 2 Hz</strong>: This refers to a train-of-four (TOF) stimulation where four stimuli are given at a frequency of 2 Hz (2 stimuli per second). It's a common method of monitoring neuromuscular blockade, especially when assessing for residual blockade. A fading response in the TOF is indicative of neuromuscular blockade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 20 Hz</strong>: This isn't a standard frequency for neuromuscular monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The frequency of tetanic stimulation used in neuromuscular monitoring is typically 50 Hz.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-120657.jpg\" alt=\"\" width=\"500\" height=\"494\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>PATTERN OF NERVE STIMULATION:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/single-twitch.jpg\" alt=\"\" width=\"1000\" height=\"1380\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Miller\u2019s Anesthesia, 9<sup>th</sup> Ed. Pg 1359</strong></span></p>",
    "correct_choice_id": 2279,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InstrumentsBased"
    ]
  },
  {
    "id": 73137,
    "choices": [
      {
        "id": 291509,
        "text": "<p><span style=\"font-size:16px;\">Pediatric controlled ventilation</span></p>"
      },
      {
        "id": 291510,
        "text": "<p><span style=\"font-size:16px;\">Adult controlled ventilation</span></p>"
      },
      {
        "id": 291511,
        "text": "<p><span style=\"font-size:16px;\">Obstetric ventilation</span></p>"
      },
      {
        "id": 291512,
        "text": "<p><span style=\"font-size:16px;\">Cardiac patients</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Jackson Rees circuit is used in: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TdavaWq.png\" width=\"580\" height=\"458\"></span></p>",
    "unique_key": "Q8518990",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320616,
    "difficulty_level": "intermediate",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Pediatric controlled ventilation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Jackson Rees circuit (also known as Mapleson F circuit) is specifically designed for:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Pediatric patients</span></li><li><span style=\"font-size:16px;\">Can be used for both spontaneous and controlled ventilation in children</span></li><li><span style=\"font-size:16px;\">It's a modification of the Ayre's T-piece with an open-ended bag</span></li><li><span style=\"font-size:16px;\">This circuit is ideal for pediatric anesthesia due to its low resistance and minimal dead space</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2eS5oRn.png\" width=\"804\" height=\"309\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Adult controlled ventilation:</strong> Not appropriate as Jackson Rees circuit is designed for pediatric patients. Adults require circuits with larger volumes and different configurations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Obstetric ventilation:</strong> Obstetric patients require specialized circuits that can deliver high flow rates and manage rapid changes in ventilation demands.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Cardiac patients:</strong> Cardiac patients typically require precise control over ventilation parameters, which is better achieved with more sophisticated circuits.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Jackson Rees circuit (Mapleson F) is specifically designed and used for pediatric anesthesia, suitable for both spontaneous and controlled ventilation.</span><br><br>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0we6aL2.png\" width=\"1119\" height=\"808\"></p>",
    "correct_choice_id": 291509,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57583,
    "choices": [
      {
        "id": 229701,
        "text": "<p><span style=\"font-size:18px;\">75</span></p>"
      },
      {
        "id": 229702,
        "text": "<p><span style=\"font-size:18px;\">100</span></p>"
      },
      {
        "id": 229703,
        "text": "<p><span style=\"font-size:18px;\">125</span></p>"
      },
      {
        "id": 229704,
        "text": "<p><span style=\"font-size:18px;\">150</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>There were 4000 live births in a community in a year. Do MMR Calculation if you come to know that 6 women died during pregnancy, labor/delivery, or within 42 days of delivery - 2 due to Obstructed labor, 1 due to Sepsis, 1 due to PPH, 1 due to Snake bite and 1 due to electrocution.</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q3256441",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320319,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Maternal Mortality Ratio (MMR) is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173703.jpg\" alt=\"\" width=\"700\" height=\"143\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In this scenario, there were 4000 live births in the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation of Maternal Deaths:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Maternal death is defined as the death of a woman during pregnancy, labor, or within 42 days of termination of pregnancy, provided the death is related to maternity or its complications.</span></li><li><span style=\"font-size:18px;\">Out of the 6 reported deaths:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">2 deaths due to Obstructed labor (included)</span></li><li><span style=\"font-size:18px;\">1 death due to Sepsis (included)</span></li><li><span style=\"font-size:18px;\">1 death due to PPH (Postpartum Hemorrhage) (included)</span></li><li><span style=\"font-size:18px;\">1 death due to Snake bite (not related to maternity, hence excluded)</span></li><li><span style=\"font-size:18px;\">1 death due to Electrocution (not related to maternity, hence excluded)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Therefore, only 4 deaths are considered maternal deaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Substituting in the formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173720.jpg\" alt=\"\" width=\"700\" height=\"154\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Maternal Mortality Ratio (MMR) is calculated as the number of maternal deaths per 100,000 live births, considering only deaths directly related to pregnancy or its complications.</span></p>",
    "correct_choice_id": 229702,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 12826,
    "choices": [
      {
        "id": 51266,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 3 </span></span></span></p>"
      },
      {
        "id": 51267,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 4 </span></span></span></p>"
      },
      {
        "id": 51268,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3 and 5 </span></span></span></p>"
      },
      {
        "id": 51269,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 and 5 </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drowned dead body of a young man found in the sea and was brought in for postmortem examination. Which of the following findings do you see in seawater drowning? (</span></span></span>INICET May 2021)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypernatremia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyponatremia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperkalemia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myocardial anoxia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemodilution</span></span></span></li>\r\n</ol>",
    "unique_key": "Q8797384",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320560,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B. 1 and 4&nbsp; </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Seawater Drowning Characteristics:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Hypernatremia:</span></strong><span style=\"font-size:12.0pt\"> Seawater is hypertonic compared to the body fluids, leading to an increase in sodium levels in the blood.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Myocardial anoxia:</span></strong><span style=\"font-size:12.0pt\"> Lack of oxygen due to drowning can lead to myocardial anoxia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fresh water drowning Vs Salt water Drowning </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-162311.png\" style=\"height:389px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Hyponatremia:</span></strong><span style=\"font-size:12.0pt\"> Seen in freshwater drowning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Hyperkalemia:</span></strong><span style=\"font-size:12.0pt\"> Seen in freshwater drowning due to hemolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">5. Hemodilution:</span></strong><span style=\"font-size:12.0pt\"> Seen in freshwater drowning due to absorption of water.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DIFFERENCES BETWEEN FRESH WATER AND SALT WATER DROWNING</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-165509.png\" style=\"height:403px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 51267,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 52368,
    "choices": [
      {
        "id": 208965,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HLA B27 is associated in 90% cases</span></span></span></p>"
      },
      {
        "id": 208966,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is non-erosive and only joints are affected</span></span></span></p>"
      },
      {
        "id": 208967,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Involvement of sacroiliac joint is earliest sign</span></span></span></p>"
      },
      {
        "id": 208968,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Affects males more than females </span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about Ankylosing spondylitis except:&nbsp;</span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1944901",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320617,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) It is non-erosive and only joints are affected</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ANKYLOSING SPONDYLITIS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ankylosing spondylitis is characterized by <strong>erosive changes</strong>. &nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AS is <strong>not completely non-erosive</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Over time, inflammation can lead to erosive changes, especially in the <strong>sacroiliac joints and the spine</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The inflammatory process in AS often leads to <strong>erosion of the vertebrae</strong> and the formation of <strong>syndesmophyte</strong> (bone spurs), which contribute to the <strong>fusion of spinal segments</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While AS primarily affects the <strong>axial skeleton</strong> (spine and sacroiliac joints), it can also involve other structures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Extra-articular manifestations&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">can include <strong>enthesitis </strong>(inflammation of the sites where tendons and ligaments attach to bone), <strong>uveitis </strong>(eye inflammation), and in some cases, <strong>systemic symptoms like fatigue and anemia.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. HLA-B27 is associated in 90% of cases:&nbsp;</span></strong><span style=\"font-size:12.0pt\">HLA-B27 is a genetic marker that is strongly associated with ankylosing spondylitis. Approximately 90% of patients with ankylosing spondylitis test positive for the HLA-B27 antigen. However, not all individuals with this antigen will develop the disease, and not all AS patients will test positive for HLA-B27. The exact role of HLA-B27 in the pathogenesis of AS is not fully understood, but it is considered a significant genetic risk factor. HLA-B27 positivity is used as part of the diagnostic process and can help in predicting the likelihood of AS in patients with symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Involvement of sacroiliac joint is earliest sign:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacroiliac joint involvement is often one of the earliest signs of ankylosing spondylitis. The sacroiliac joints are typically among the first to be affected in AS. Early symptoms include lower back pain and stiffness that improves with activity and worsens with rest. X-rays or MRI of the sacroiliac joints can reveal characteristic changes associated with AS, such as sacroiliitis (inflammation of the sacroiliac joints) and eventually, structural changes such as joint fusion.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/25/screenshot-2024-07-25-132229.jpg\" style=\"height:296px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Affects males more than females:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ankylosing spondylitis is more common in males than females. Studies suggest that the male-to-female ratio for AS is approximately 2:1 to 3:1. The disease may present differently in women, sometimes leading to a delay in diagnosis. Women with AS might have a less pronounced spinal involvement and more peripheral joint symptoms compared to men.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ankylosing spondylitis is an erosive inflammatory condition in which axial skeleton particularly in the spine and sacroiliac joints and other organs are affected. </span></span></li>\r\n</ul>",
    "correct_choice_id": 208966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InstrumentsBased"
    ]
  },
  {
    "id": 4212,
    "choices": [
      {
        "id": 16825,
        "text": "<p><span style=\"font-size:12.0pt;\">Enterotoxigenic Escherichia coli</span></p>"
      },
      {
        "id": 16826,
        "text": "<p><span style=\"font-size:12.0pt;\">Enteropathogenic Escherichia coli</span></p>"
      },
      {
        "id": 16827,
        "text": "<p><span style=\"font-size:12.0pt;\">Enteroinvasive Escherichia coli</span></p>"
      },
      {
        "id": 16828,
        "text": "<p><span style=\"font-size:12.0pt;\">Diffusely adherent Escherichia coli</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which pathogen causes attachment-effacement lesion in the intestinal mucosa?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2021)</span></p>",
    "unique_key": "Q1971568",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320624,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Enteropathogenic Escherichia coli</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Attaching-and-effacing is the \u201challmark\u201d of the EPEC infections, a lesion that is characterized by the intimate attachment of the bacteria to the host epithelial cell membrane and the effacement of the microvilli. This mechanism is a hallmark of EPEC infections, leading to copious watery diarrhea, especially in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Enterotoxigenic Escherichia coli (ETEC):</strong></span>&nbsp;<span style=\"font-size:12.0pt;\"><strong>Incorrect:</strong> ETEC causes watery diarrhea through the production of enterotoxins that increase cyclic AMP (cAMP) or cyclic GMP (cGMP) levels, leading to fluid and electrolyte loss. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Enteroinvasive Escherichia coli (EIEC):&nbsp;Incorrect:</strong> EIEC invades and destroys epithelial cells lining the colon, leading to fever, cramping, watery diarrhea, and dysentery with scant, bloody stools. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diffusely adherent Escherichia coli (DAEC):&nbsp;Incorrect:</strong> DAEC is known for its diffuse adherence pattern to epithelial cells, causing persistent diarrhea in children. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-171808.png\" alt=\"\" width=\"1000\" height=\"818\"></p>",
    "correct_choice_id": 16826,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 57574,
    "choices": [
      {
        "id": 229665,
        "text": "<p><span style=\"font-size:18px;\">Tetanus</span></p>"
      },
      {
        "id": 229666,
        "text": "<p><span style=\"font-size:18px;\">Measles</span></p>"
      },
      {
        "id": 229667,
        "text": "<p><span style=\"font-size:18px;\">Rubella</span></p>"
      },
      {
        "id": 229668,
        "text": "<p><span style=\"font-size:18px;\">Influenza</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which disease is represented by the submerged portion of the iceberg in the iceberg model?</strong><i><strong> [NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173317.jpg\" alt=\"\" width=\"400\" height=\"281\"></strong></span></p>",
    "unique_key": "Q3147801",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320311,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Influenza</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The iceberg model represents diseases that have a visible portion (the tip) and a hidden portion (submerged part). The tip of the iceberg represents clinical cases that are easily diagnosed by healthcare providers, typically through visible symptoms. The submerged portion, which is much larger, represents the hidden cases, including asymptomatic, subclinical, latent, and pre-symptomatic individuals who still carry the disease but are not easily visible to healthcare providers.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Influenza exhibits the iceberg phenomenon because many individuals with the virus remain undiagnosed as they show mild or no symptoms. These hidden cases contribute significantly to the spread of the disease as these individuals do not seek medical attention and thus remain below the surface of clinical observation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Tetanus:</strong> Tetanus does not exhibit the iceberg phenomenon because it does not have carriers or asymptomatic cases. The disease only manifests as clinical cases, which are visible to healthcare providers.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Measles:</strong> Measles does not have an iceberg phenomenon due to the absence of carriers and asymptomatic cases. It is typically a visible disease with noticeable symptoms once infection occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Rubella:</strong> Similar to measles, rubella also does not have an iceberg phenomenon as it does not involve carriers or hidden cases. The infection is primarily identified through its clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The iceberg phenomenon describes diseases with a significant proportion of hidden, asymptomatic, or subclinical cases, such as influenza, which contribute to disease transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Remember \u2013 No carriers \u2013 No iceberg Phenomena \u2013 Measles, Rubella, Rabies, Tetanus and <u>+ </u>Pertussis</strong></span></p>",
    "correct_choice_id": 229668,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10345,
    "choices": [
      {
        "id": 41346,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 41347,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
      },
      {
        "id": 41348,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 41349,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following increase the risk of recurrence of febrile seizures? (INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Age &lt; 1 year</span></li><li><span style=\"font-size:12.0pt;\">Temperature of 38-39\u00b0C</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever &lt; 24 h</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever &gt; 48 h</span></li></ol>",
    "unique_key": "Q7383663",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320543,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children who are less than 1 year old, have a fever with a temperature between 38-39\u00b0C, and have a fever duration of less than 24 hours. Febrile seizures typically occur in children between the ages of 6 and 60 months and are generalized tonic-clonic seizures that occur in the setting of fever without any underlying intracranial infection or a previous history of unprovoked seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Risk Factors:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Age &lt; 1 year:&nbsp;</strong>Younger age increases the likelihood of recurrent febrile seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Temperature of 38-39\u00b0C:&nbsp;</strong>Lower fever temperatures (38-39\u00b0C) are associated with a higher risk of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Duration of fever &lt; 24 h:&nbsp;</strong>A shorter duration of fever before the onset of seizures is associated with an increased risk of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Information:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Minor risk factors&nbsp;</strong>for recurrence include male gender, attending daycare, having complex febrile seizures, a family history of febrile seizures, and lower serum sodium levels at presentation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Duration of fever &gt; 48 hours:&nbsp;</strong>A duration of fever greater than 48 hours is not considered a risk factor for febrile seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children under 1 year of age, with fever temperatures between 38-39\u00b0C, and fever lasting less than 24 hours.</span></p>",
    "correct_choice_id": 41348,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 20353,
    "choices": [
      {
        "id": 81373,
        "text": "<p><span style=\"font-size:18px;\">Aflatoxin</span></p>"
      },
      {
        "id": 81374,
        "text": "<p><span style=\"font-size:18px;\">Beta-oxalyl-amino-alanine</span></p>"
      },
      {
        "id": 81375,
        "text": "<p><span style=\"font-size:18px;\">Ergot alkaloids</span></p>"
      },
      {
        "id": 81376,
        "text": "<p><span style=\"font-size:18px;\">Fusarium toxin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A poor farmer with a history of successive crop failure develops progressive spastic paraparesis, signs of upper motor neuron paralysis, and gait instability. Name the toxin responsible for this condition. </strong><i><strong>[NEET PG &nbsp;2023]</strong></i></span></p>",
    "unique_key": "Q7406975",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320330,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Beta-oxalyl-amino-alanine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Given clinical scenario points to a diagnosis of neurolathyrism, for which the toxin responsible is beta-oxalyl-amino-alanine (BOAA).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Lathyrism is of two types:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Neurolathyrism: In human beings</span></li><li><span style=\"font-size:18px;\">Osteolathyrism: In animals</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Neurolathyrism is caused by eating the pulse \u2018Khesari Dal (Lathyrus sativus)\u2019. Diets containing over 30% of this dal consumed over a period of 2 - 6 months result in neurolathyrism</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Lathyrism affects 15 - 45 years of age</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Toxin: present in lathyrus seeds is \u2018Beta oxalyl amino alanine (BOAA)\u2019Q</span></li><li><span style=\"font-size:18px;\">It manifests as following stages:</span><ul><li><span style=\"font-size:18px;\">Latent stage</span></li><li><span style=\"font-size:18px;\">No-stick stage</span></li><li><span style=\"font-size:18px;\">One-stick stage</span></li><li><span style=\"font-size:18px;\">Two-stick stage</span></li><li><span style=\"font-size:18px;\">Crawler stage</span></li></ul></li><li><span style=\"font-size:18px;\">Interventions for prevention and control of Lathyrism:</span><ul><li><span style=\"font-size:18px;\">Vitamin C</span></li><li><span style=\"font-size:18px;\">Banning the crop</span></li><li><span style=\"font-size:18px;\">Removal of toxin: Steeping method and Parboiling</span></li><li><span style=\"font-size:18px;\">Education</span></li><li><span style=\"font-size:18px;\">Genetic approach</span></li><li><span style=\"font-size:18px;\">Socio-economic changes</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Aflatoxin:&nbsp;</strong>Toxin produced by Aspergillus species. It causes aflatoxicosis and is commonly found in contaminated ground nuts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Ergot alkaloids:&nbsp;</strong>Toxins produced by Claviceps species, leading to ergotism. Found in contaminated cereals.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Fusarium toxin:&nbsp;</strong>Toxins produced by Fusarium species, which can contaminate grains and other food products, causing fusarium toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Food Adulteration Diseases</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100324.png\" alt=\"\" width=\"1000\" height=\"417\"></span></p>",
    "correct_choice_id": 81374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 20354,
    "choices": [
      {
        "id": 81377,
        "text": "<p><span style=\"font-size:18px;\">Human tetanus immunoglobulin and full course of vaccine</span></p>"
      },
      {
        "id": 81378,
        "text": "<p><span style=\"font-size:18px;\">Human tetanus immunoglobulin only</span></p>"
      },
      {
        "id": 81379,
        "text": "<p><span style=\"font-size:18px;\">Single-dose tetanus toxoid</span></p>"
      },
      {
        "id": 81380,
        "text": "<p><span style=\"font-size:18px;\">Full course tetanus toxoid</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?</strong><i><strong> [NEET PG 2023]</strong></i></span></p>",
    "unique_key": "Q5463082",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320331,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Single-dose tetanus toxoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The patient presents with a clean-cut wound and has a history of receiving a full course of tetanus vaccination 10 years ago. Based on the guidelines for tetanus prophylaxis, the appropriate management for this patient falls under the category where the patient has received a complete course of tetanus vaccination more than 5 years ago but less than 10 years ago.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Management of Tetanus-Prone Wounds:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100645.png\" alt=\"\" width=\"1000\" height=\"222\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">CC = Complete course; TIG = Tetanus Immunoglobulin</span></p>",
    "correct_choice_id": 81379,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 57576,
    "choices": [
      {
        "id": 229673,
        "text": "<p><span style=\"font-size:18px;\">Odds Ratio</span></p>"
      },
      {
        "id": 229674,
        "text": "<p><span style=\"font-size:18px;\">Chi-square test</span></p>"
      },
      {
        "id": 229675,
        "text": "<p><span style=\"font-size:18px;\">Paired student\u2019s t-test</span></p>"
      },
      {
        "id": 229676,
        "text": "<p><span style=\"font-size:18px;\">McNemar test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A study was undertaken to evaluate the effect of Dietary modification on Serum cholesterol. A group of 100 people were chosen. Their mean cholesterol levels were measured before and after dietary modification. Which statistical test should be applied to test significance? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q4687438",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320313,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Paired student\u2019s t-test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The paired student\u2019s t-test is used when comparing the means of two related groups, specifically when data is collected from the same individuals before and after an intervention. In this question, the study measures serum cholesterol levels before and after dietary modification in the same group of people, making the data paired. This test is ideal for assessing whether the mean difference between the paired observations (pre- and post-intervention) is statistically significant.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Since the data is quantitative and normally distributed, a parametric test such as the paired t-test is appropriate. The paired t-test accounts for the fact that each participant has two related measurements (before and after), which reduces variability compared to independent measurements.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Odds Ratio:</strong>&nbsp; This option is incorrect because the odds ratio is used to measure the association between two categorical variables, not for comparing means of quantitative data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Chi-square test:&nbsp;</strong> This test is used to compare categorical data and is not suitable for comparing means of quantitative measurements.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. McNemar test:&nbsp;</strong> This test is used to analyze paired categorical data, specifically for before-and-after studies with binary outcomes, not for comparing continuous variables like cholesterol levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The paired student\u2019s t-test is the appropriate statistical test for comparing means of paired quantitative data collected from the same group before and after an intervention.</span></p>",
    "correct_choice_id": 229675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57586,
    "choices": [
      {
        "id": 229713,
        "text": "<p><span style=\"font-size:18px;\">Blood culture</span></p>"
      },
      {
        "id": 229714,
        "text": "<p><span style=\"font-size:18px;\">Widal test</span></p>"
      },
      {
        "id": 229715,
        "text": "<p><span style=\"font-size:18px;\">Stool culture</span></p>"
      },
      {
        "id": 229716,
        "text": "<p><span style=\"font-size:18px;\">Urine culture</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 30-year-old male travels frequently and has food during his travels. He presents to PHC OPD with abdominal pain, fever for 4 days. He has bradycardia too. Test for confirmation of diagnosis: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q7158253",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320322,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(a) Blood culture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The clinical presentation suggests a diagnosis of enteric fever (typhoid), characterized by abdominal pain, fever, and bradycardia. The appropriate diagnostic test depends on the stage of the illness:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Blood culture</strong> is the test of choice from the first week of illness onwards. It remains the most reliable test in the initial stages (within the first week of symptoms) to confirm typhoid fever. This test directly detects the presence of Salmonella bacteria in the blood, making it the most accurate diagnostic method during early illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Widal test</strong>: This serological test detects antibodies against Salmonella and is typically used from the second week of illness onwards. It is not the preferred test during the first week as antibodies may not yet be present in detectable quantities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Stool culture</strong>: This is used from the third week of illness onwards and detects Salmonella in the gastrointestinal tract. It is not suitable for early diagnosis as it becomes positive later in the disease course.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Urine culture</strong>: This is used from the fourth week of illness onwards. It detects Salmonella excreted in the urine, but like stool culture, it is useful later in the course of the disease and not for initial diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">For typhoid fever diagnosis in the first week of illness, <strong>blood culture</strong> is the most appropriate and reliable test.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Mnemonic \u2013 BASU</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Blood culture \u2013 1<sup>st</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Antibody test (Widal) \u2013 2<sup>nd</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Stool culture \u2013 3<sup>rd</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Urine culture \u2013 4<sup>th</sup> week onwards</span></p>",
    "correct_choice_id": 229713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG"
    ]
  },
  {
    "id": 57584,
    "choices": [
      {
        "id": 229705,
        "text": "<p><span style=\"font-size:18px;\">Monovalent with 1 dose</span></p>"
      },
      {
        "id": 229706,
        "text": "<p><span style=\"font-size:18px;\">Monovalent with 2 doses</span></p>"
      },
      {
        "id": 229707,
        "text": "<p><span style=\"font-size:18px;\">Bivalent with 1 dose</span></p>"
      },
      {
        "id": 229708,
        "text": "<p><span style=\"font-size:18px;\">Bivalent with 2 doses</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>True regarding Oral Cholera vaccine \u2018Sanchol\u2019 is: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q2366169",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320320,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(d) Bivalent with 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The oral cholera vaccine \u2018Sanchol\u2019 is a bivalent vaccine designed to protect against serotypes O1 and O139 of the cholera bacteria. It is administered as 2 liquid doses for individuals aged 1 year and older, with a booster dose recommended every 2 years. The vaccine does not contain subunit B antitoxin; hence it does not require a buffer during administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\"><strong>CHOLERA ORAL VACCINES:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">&nbsp;Dukoral (WC-rBS): Monovalent, V cholera O1 plus Recombinant Toxin B subunit.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">2 doses (if age \u22656 years) and booster once/ 2 years</span></li><li><span style=\"font-size:18px;\">3 doses (if age b/w 2-5 years) and booster dose once per 6 months.</span></li></ul></li><li><span style=\"font-size:18px;\">&nbsp;Sanchol and mORCVAX: Bivalent, Serogroups O1 &amp; O139, No toxin B subunit, No buffer required. 2 liquid doses after the age of 1 year and booster after 2 years.</span></li><li><span style=\"font-size:18px;\">Euvichol: it is just like Sanchol. Bivalent with 2 doses.</span></li></ul>",
    "correct_choice_id": 229708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 13915,
    "choices": [
      {
        "id": 55621,
        "text": "<p><span style=\"font-size:12.0pt;\">Red nucleus</span></p>"
      },
      {
        "id": 55622,
        "text": "<p><span style=\"font-size:12.0pt;\">Sub thalamic nuclei</span></p>"
      },
      {
        "id": 55623,
        "text": "<p><span style=\"font-size:12.0pt;\">Decussation of pyramidal tract</span></p>"
      },
      {
        "id": 55624,
        "text": "<p><span style=\"font-size:12.0pt;\">Olivary nucleus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">At which level does the nerve supply for the marked structure arise? (</span>INICET May 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture1_D7XdOGB.jpg\" alt=\"\" width=\"300\" height=\"169\"></p><p>&nbsp;</p>",
    "unique_key": "Q9215337",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320621,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Red nucleus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The medial rectus muscle is the one highlighted in the provided CT picture. The oculomotor nerve, whose nucleus is located at the level of the superior colliculus adjacent to the red nucleus, supplies the medial rectus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nuclear complex from which the oculomotor nerve arises consists of:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Several groups of large motor neurons are collectively called the oculomotor nucleus. The motor neuron groups of the oculomotor nucleus innervate, in dorsoventral order, the ipsilateral inferior rectus, inferior oblique, and medial rectus. A medially placed column of cells innervates the contralateral superior rectus.</span></li><li><span style=\"font-size:12.0pt;\">Smaller preganglionic parasympathetic neurons called the Edinger-Westphal preganglionic nucleus</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Subthalamic nuclei</strong>: The subthalamic nucleus is part of the diencephalon and is closely associated with the basal ganglia circuitry. It plays a role in motor control. It's not directly associated with the oculomotor nerve's origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Decussation of pyramidal tract</strong>: The decussation of the pyramidal tract (motor fibers) occurs in the lower medulla oblongata, well below the level of the oculomotor nerve's origin. This is where the majority of motor fibers from one hemisphere cross to the opposite side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Olivary nucleus</strong>: The olivary nucleus is located in the medulla oblongata and is primarily associated with the coordination of motor tasks. Again, it's located caudally relative to the oculomotor nerve's origin in the midbrain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The oculomotor nerve (CN III) arises from the anterior aspect of the midbrain, at the level of the superior colliculus. Its nucleus is situated ventral to the cerebral aqueduct and in close proximity to the red nucleus. Hence, the oculomotor nerve is often associated with the level of the red nucleus in the midbrain. It exits the midbrain medial to the cerebral peduncle.</span></p>",
    "correct_choice_id": 55621,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57594,
    "choices": [
      {
        "id": 229745,
        "text": "<p><span style=\"font-size:18px;\">Remove IUD gently, then do MTP</span></p>"
      },
      {
        "id": 229746,
        "text": "<p><span style=\"font-size:18px;\">Remove IUD gently</span></p>"
      },
      {
        "id": 229747,
        "text": "<p><span style=\"font-size:18px;\">Do MTP directly</span></p>"
      },
      {
        "id": 229748,
        "text": "<p><span style=\"font-size:18px;\">Leave IUD in situ</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 29-year-old woman had an IUD inserted at a PHC. After a few months, she conceives. On examination, the IUD is still in place. She wants to continue with her pregnancy. Next best step of management is? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q1375213",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320323,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Remove IUD gently</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In cases where a woman becomes pregnant with an intrauterine device (IUD) still in place and wishes to continue with the pregnancy, the standard approach is to gently remove the IUD if the threads are visible and accessible. Removal of the IUD reduces the risk of complications such as infection, preterm labor, and spontaneous abortion. Gently pulling the IUD threads minimizes trauma and associated risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">However, it is important to counsel the patient about the increased risk of spontaneous abortion even after the removal of the IUD, but removal is generally recommended to avoid ongoing complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Remove IUD gently, then do MTP</strong>: This is incorrect because performing Medical Termination of Pregnancy (MTP) is not mandatory and cannot be enforced unless the patient chooses it. The primary goal here is to safely remove the IUD, not to proceed directly with MTP.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Do MTP directly</strong>: This option is incorrect because the patient explicitly wants to continue the pregnancy. MTP should not be performed without the patient\u2019s consent, and it is not a management step in this case unless requested by the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Leave IUD in situ</strong>: Leaving the IUD in place is not advisable as it poses a high risk of adverse outcomes, including infections, miscarriage, and preterm birth. The safest option is to remove the IUD if possible.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">If a woman conceives with an IUD in place and wishes to continue the pregnancy, the IUD should be gently removed to minimize the risk of complications.</span></p>",
    "correct_choice_id": 229746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10247,
    "choices": [
      {
        "id": 40954,
        "text": "<p><span style=\"font-size:18px;\">Primary health center</span></p>"
      },
      {
        "id": 40955,
        "text": "<p><span style=\"font-size:18px;\">District hospital</span></p>"
      },
      {
        "id": 40956,
        "text": "<p><span style=\"font-size:18px;\">Sub-centre</span></p>"
      },
      {
        "id": 40957,
        "text": "<p><span style=\"font-size:18px;\">Sub-divisional hospital</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which entity is responsible for managing the school health programs? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
    "unique_key": "Q5682600",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320340,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Primary health center</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In India, the School Health Committee recommended that school health services be integrated with general health services, which are managed by primary health centers (PHCs).</span></li><li><span style=\"font-size:18px;\">To ensure effective implementation, the committee proposed the formation of school health committees at various levels. PHCs are responsible for providing a range of school health services such as health assessments, vision and hearing tests, dental check-ups, treatment for common illnesses, immunization, micronutrient management, deworming, and provision of mid-day meals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Primary Health Centers (PHCs) are responsible for managing school health programs in India, providing a range of health services to ensure the well-being of school children.</span></p>",
    "correct_choice_id": 40954,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 14407,
    "choices": [
      {
        "id": 57589,
        "text": "<p><span style=\"font-size:12.0pt;\">Supine with neck flexion.</span></p>"
      },
      {
        "id": 57590,
        "text": "<p><span style=\"font-size:12.0pt;\">Supine with neck extension</span></p>"
      },
      {
        "id": 57591,
        "text": "<p><span style=\"font-size:12.0pt;\">Sitting with neck flexion</span></p>"
      },
      {
        "id": 57592,
        "text": "<p><span style=\"font-size:12.0pt;\">Sitting with neck extension</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old female is admitted to the hospital with complaints of vomiting and abdominal distention. A nasogastric (NG) tube is inserted to decompress the stomach. However, the patient remains conscious and alert during the procedure. What is the best position to place the patient in during the insertion of the NG tube? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q6240720",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320570,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sitting with neck flexion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the <strong>best position for a conscious patient during Ryle's tube insertion</strong>. Sitting allows for better alignment of the upper gastrointestinal tract, making it easier to guide the tube through the esophagus and into the stomach. Neck flexion helps align the crico-pharynx with the Ryle\u2019s tube, reducing faulty tracheal insertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best position for a conscious patient to be in during the insertion of Ryle's tube is sitting with neck flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confirmation of the correct position of RT is done by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Auscultation in the epigastric area while injecting a bolus of air</span></li><li><span style=\"font-size:12.0pt;\">Aspiration of gastric contents</span></li><li><span style=\"font-size:12.0pt;\">X-ray chest + upper abdomen</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The approximate length of the Ryle\u2019s tube is 120-125 cm. There are 4 markings on the tube which indicates the traversing of the tube through various parts of the stomach</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">40 cm - Tube has traversed cardia of the stomach</span></li><li><span style=\"font-size:12.0pt;\">50 cm - Tube has traversed body of the stomach</span></li><li><span style=\"font-size:12.0pt;\">60 cm - Tube has traversed pylorus</span></li><li><span style=\"font-size:12.0pt;\">70 cm - Tube has traversed duodenum</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The length of tube to be inserted is calculated by measuring the distance between nose-tip of ear lobule-xiphoid (N-E-X rule).</span></p>",
    "correct_choice_id": 57591,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ]
  },
  {
    "id": 57578,
    "choices": [
      {
        "id": 229681,
        "text": "<p><span style=\"font-size:18px;\">Don\u2019t do the USG scan</span></p>"
      },
      {
        "id": 229682,
        "text": "<p><span style=\"font-size:18px;\">Do USG, don\u2019t see the fetus gender and don\u2019t tell the woman</span></p>"
      },
      {
        "id": 229683,
        "text": "<p><span style=\"font-size:18px;\">Do USG, see the fetus gender and don\u2019t tell the woman</span></p>"
      },
      {
        "id": 229684,
        "text": "<p><span style=\"font-size:18px;\">Do USG, see the fetus gender and tell the woman</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>G5P4 lady with 4 female children reports for the first time at 18 weeks POG. As per the PCPNDT Act and Beti Bachao Andolan, what will you do? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q1951645",
    "question_audio": null,
    "question_video": null,
    "map_id": 34320402,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Do USG, don\u2019t see the fetus gender and don\u2019t tell the woman</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In India, the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994, strictly prohibits the determination of fetal sex to prevent female feticide. The act is a legal measure to curb the misuse of diagnostic techniques for sex determination, which could lead to gender-selective abortions. This law aligns with the Beti Bachao Beti Padhao initiative, which aims to save and educate the girl child.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In the given scenario, the woman is at 18 weeks of gestation. A USG (ultrasound) scan is recommended to assess fetal health and pregnancy progress but not to determine the fetus's gender. Neither the radiologist nor the obstetrician/gynecologist should attempt to determine or disclose the fetus's gender unless there is a valid legal or medical reason, which is rare and strictly controlled.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Don\u2019t do the USG scan: </strong>This option is incorrect because USG is an important tool for monitoring fetal development and maternal health. Refusing to perform a USG scan without medical justification would be inappropriate and neglectful of standard prenatal care.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Do USG, see the fetus gender and don\u2019t tell the woman:&nbsp; </strong>This option is incorrect because, under the PCPNDT Act, healthcare professionals are prohibited from determining the gender of the fetus during a USG scan unless medically indicated. Viewing the fetus's gender without a valid reason is a violation of the law.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp; Do USG, see the fetus gender and tell the woman: </strong>This option is incorrect and illegal as per the PCPNDT Act. Disclosing the gender of the fetus to the expectant mother or any other person is punishable by law, as it could lead to gender-based discrimination and sex-selective abortions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Fetal sex determination and disclosure are illegal under the PCPNDT Act unless medically indicated. During routine prenatal care, USG should be performed without determining or revealing the fetus's gender.</span></p>",
    "correct_choice_id": 229682,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  }
];
        let quizName = 'Late Night Pyq (Inicet, Mixed Bag-14)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>